Loading...
HomeMy WebLinkAboutContract 64067CSC No. 64067 STATE OF TEXAS COUNTY OF TARRANT § § § This contract ("Contract") is made and entered into by and between the City of Fort Worth (hereafter "City") and The University of North Texas Health Science Center at Fort Worth (hereafter "Agency"). City and Agency may be referred to individually as a "Party" and jointly as "the Parties". WHEREAS, the State of Texas and certain political subdivisions, through their elected representatives and counsel, seek to hold entities responsible for the opioid use and distribution within the State of Texas and share a common desire to abate and alleviate the impacts of the opioid epidemic throughout the state; WHEREAS, through the adoption of Resolution 5499-11-2021 on November 9, 2021, City Council joined the opioid settlement negotiated by the Texas Attorney General, affirmed its support for the adoption and approval of the Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet, and found that there is a substantial need for repayment of opioid-related expenditures and payment to abate opioid-related harms in and about Fort Worth; WHEREAS, the City of Fort Worth received settlement payments from the Opioid Abatement Fund Council totaling $761,379.85, including $129,518.88 in April 2024 and $631,860.97 on April 10, 2025; and WHEREAS, the use of these funds was approved by the City Council in June 2025, as documented in Mayor and Council Communication (M&C 25-0586); WHEREAS, the City's Neighborhood Services Department has been designated as the lead department to oversee allocation and use of these funds and issued a Request for Proposals from nonprofit and social service agencies offering direct social services for the intervention, prevention, and treatment of opioid use disorder (OUD) and any co-occurring Substance Use Disorder or Mental Health (SUD/MH) conditions; WHEREAS, Agency has been selected by City to provide these services in an attempt to help alleviate the impacts of opioid use in the City of Fort Worth. NOW, THEREFORE, the Parties understand and agree as follows: 1. INCORPORATION OF RECITALS. City and Agency hereby agree that the recitals set forth above are true and correct and form the basis upon which the Parties have entered into this Contract. 2. DEFINITIONS. In addition to terms defined in the body of this Contract, the terms set forth below shall have the definitions ascribed to them as follows: INTERVENTIONS OF OPIOID USE CONTRACT The University of North Texas Health Science Center at Fort Worth Page 1 OFFICIAL RECORD CITY SECRETARY FT. WORTH, TX Complete Documentation means Exhibit "D" Reimbursements Forms, with the following documents included to substantiate eligible reimbursement expenses: • Cover Page signed by Agency's authorized signatory • General Ledger Reports (monthly, generated from Agency's accounting system); • Payroll Reports (monthly, generated from Agency's payroll system) if reimbursement request includes personnel • Effort Certification (bi-annually) • Expense Report • Invoice • Proof of Payment • Client Data Report • Any other document reasonably necessary to verify eligible expenses. Complete Documentation shall meet the standards described in the attached EXHIBIT "F" - Standards for Complete Documentation. Director means the Director of the Neighborhood Services Department. Effective Date means October 1, 2025. IOU means Interventions of Opioid Use. Neighborhood Services Department means the City's Neighborhood Services Department. Neighborly Software means the online database for Agency to submit quarterly reimbursement requests. OPIOID FUNDS mean those funds provided to City as part of a settlement from the Opioid Abatement Fund Council that have been allocated by City Council to help alleviate the impacts of opioid use in the City of Fort Worth. Program means the services described in EXHIBIT "B" — Program Summary. Reimbursement Request means all reports and other documentation required under Section 9. Unduplicated Clients means a count of all clients served by the Program at least once in the Contract Term. Clients served by the Program more than once in the Contract Term will only be counted the first time they are served when determining the total count of Unduplicated Clients. 3. TERM. The term of this Contract begins on the Effective Date and terminates on September 30, 2026, unless earlier terminated as provided in this Contract. This Contract may be extended by mutual agreement of the Parties in writing if such extension is necessary for completion of the program, or to amend the contracts if necessary to achieve program goals provided any amendment INTERVENTIONS OF OPIOID USE CONTRACT Page 2 The University of North Texas Health Science Center at Fort Worth is within the scope of the program and in compliance with City policies and all applicable laws and regulations. The Contract term shall include any extension, if exercised, as provided herein. 4. DUTIES AND RESPONSIBILITIES OF CITY. 4.1 Provide OPIOID Funds. City shall provide up to $227,156.00 of OPIOID-Funds under the terms and conditions of this Contract. 4.2 Monitor. City will monitor the activities and performance of Agency and any of its contractors, subcontractors or vendors as necessary, but no less than annually. Monitoring by City will include determining whether Agency is utilizing funds in compliance with the "Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet" and "List of Opioid Remediation Uses" approved by the Texas Attorney General, attached as Exhibit "A" and Exhibit "E." 5. DUTIES AND RESPONSIBILITIES OF AGENCY. 5.1 Required Services. Agency shall perform the services described in EXHIBIT "B" — Program Summary in accordance with the terms and conditions of this Contract. 5.2 Use of OPIOID Funds. 5.2.1. Compliance with OPIOID Term Sheet and Contract. Agency shall be reimbursed for eligible Program costs with OPIOID Funds only if: 5.2.1.1 Costs are eligible expenditures in accordance with Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet (hereinafter, "OPIOID Term Sheet"), attached as Exhibit "A," and in particular the "List of Opioid Remediation Uses," attached as Exhibit "E„ 5.2.1.2 Costs are in compliance with this Contract and are reasonable. 5.2.1.3 Complete Documentation, as applicable, is submitted to City by Agency. 5.2.2 Budget. 5.2.2.1 The OPIOID Funds will be paid on a reimbursement basis in accordance with EXHIBIT "C" - Budget. INTERVENTIONS OF OPIOID USE CONTRACT Page 3 The University of North Texas Health Science Center at Fort Worth 5.2.2.2 During the term of this Contract, Agency may submit written requests to increase or decrease line -item amounts in the Budget, including an explanation of why such increases or decreases are necessary. All requests shall be approved by Director or Director's designee in writing, with such approval being in the City's sole discretion. If the Agency's proposed Budget amendment is approved (as approved, the "Amended Budget"), then the Amended Budget shall be memorialized in a written amendment to this Contract. The Amended Budget will take effect on the first day of the month following the month in which the Contract amendment is executed, unless otherwise specified in the amendment. 5.2.3 Change in Program Budget. 5.2.3.1 Agency will notify City promptly of any additional funds it receives for operation of the Program, and City reserves the right to amend this Contract in such instances to ensure compliance with The Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet governing cost allocation. 5.2.3.2 Agency agrees to utilize the OPIOID Funds to supplement rather than supplant funds otherwise available for the Program. 5.2.4 Payment of OPIOID Funds to Agency. OPIOID Funds will be disbursed to Agency upon City's approval of Reimbursement Requests including submission of Complete Documentation to City in compliance with Section 9. It is expressly agreed by the Parties that any OPIOID Funds not spent or approved for reimbursement to Agency shall remain with City. 5.3 Program Performance Milestones, Review and Corrective Action Plans 5.3.1 Agency represents that the Program will achieve the following milestones in accordance with EXHIBIT `B" — Program Summary and the table below: Month Expenditures r Unduplicated Clients as specified in EXHIBIT "B" — Program Summary 3 25% 25% 6 50% 50% 9 75% 75% 12 100% 100% 5.3.2 Failure of Agency to meet these milestones or a material deviation from them as outlined in this Section 5.3 may result in corrective action, provided that City has notified Agency INTERVENTIONS OF OPIOID USE CONTRACT The University of North Texas Health Science Center at Fort Worth Page 4 of such failure or material deviation in writing and provided fifteen (15) days for Agency to cure the failure or material deviation. For the purpose of this Section, "material deviation" shall mean more than 10% lower than the specified goal. In the event of such failure or material deviation, City reserves the right in its sole option to (i) institute a Corrective Action Plan ("CAP") as described below, (ii) reduce Agency's allocation of OPIOID Funds, (iii) terminate this Contract, or any combination of the above options. 5.3.2.1 Policy. To ensure the Program meets the client goals provided by Agency and included herein, City will periodically review Program performance to ensure the expenditure of the funds is roughly proportional to the number of eligible, unduplicated clients being served, as described above in 5.3.1. City expects that most programs will expend funds in a proportional amount to clients served, but City reserves the ability to take into account unique program characteristics that may impact the ratio between expenditures and clients served. As such, City will require Agency to provide written documentation related to: (1) marketing efforts provided by Agency, (2) the number of clients that were provided training, (3) the number of clients that received opioid kits from Agency, and (4) the number of clients who were provided drug counseling. 5.3.2.2 Review. At the end of each quarter, City will review the information in the required reports provided to City by Agency- including the attachments in Exhibit "D" and Exhibit "F" and any supporting documentation as listed in Exhibit "F." City will review the amount of funds expended compared to the percentage of eligible, unduplicated clients served. If City believes in its sole discretion that Agency is (i) in danger of not spending the full amount of the funds allocated, (ii) in danger of expending all funds prior to serving 100% of the unduplicated client goal (meaning the percentage of funds expended relative to the overall funding allocated is not within 10% of the percentage of eligible, unduplicated clients served relative to the overall client goal), or is (iii) in danger of not otherwise meeting the performance goals within this Contract, City will notify Agency and set up a Program Review Meeting ("Review Meeting"). Failure by Agency to attend the Review Meeting is considered a breach of this contract and City may invoke any and all remedies included herein. During the Review Meeting, City and Agency will review the information provided, the Program, and discuss any concerns. If the City believes that no additional action is needed to ensure Agency's performance, no additional requirements will be put in place; however, if the City, in its sole discretion, believes that additional requirements are needed to ensure Agency's performance, City may take corrective action as outlined above. 5.3.2.3 Corrective Action Plans. A CAP will be unique to the Agency and the Program and will be designed to ensure that the Agency (i) expends the funds allocated to it by the City, and (ii) serves the required number of unduplicated clients through the Program. A CAP may require additional outreach or marketing, additional reporting, additional monitoring, or any other mechanism that will reasonably ensure the Program goals are met and that expenditures are roughly proportional to the number of eligible, unduplicated clients served. 5.3.2.4 Deobligation of Funds If after a quarterly review the City determines that a CAP will not be sufficient to ensure INTERVENTIONS OF OPIOID USE CONTRACT Page 5 The University of North Texas Health Science Center at Fort Worth that the Agency (i) expends the funds allocated to it by the City, and (ii) serves the required number of unduplicated clients through the Program, City shall be able to deobligate a portion of the funds provided to Agency that is at -risk of not being expended or that is the proportional amount of funds compared to the number of eligible, unduplicated clients that are anticipated to not be served. Any deobligation shall be in the form of a contract amendment. By way of example, if an agency was allocated $100,000 and was required to serve 100 unduplicated clients, and that agency was expected to only be able to serve 75% of its client goal, then City would allow agency to keep 75% of the allocated funding and deobligate 25% of the funds to correspond with the 25% of clients that are anticipated to not be served. 5.3.3 Failure to comply with the Corrective Action Plan (CAP), meet milestones listed under Section 5.3.1, or otherwise comply with serving the number of unduplicated clients stated in Exhibit "B" may, in City's sole discretion, disqualify Agency for consideration under the City's Request for Proposals for the 2026-2027 Program Year for OPIOID funds. In the event Agency successfully completes the requirements and goals under the Corrective Action Plan, and submits all required documentation, it will be reimbursed for all eligible expenses and will still be considered for future Program Years. 5.3.4 Amendments to performance milestones regarding OPIOID Funds must be approved by the Director in writing, with such approval being in the Director's sole discretion. If Director approves the Agency's proposed amended performance milestones (as approved, the "Amended Performance Milestones"), then the Amended Performance Milestones shall be memorialized in a written amendment to this Contract. The Amended Performance Milestones will take effect on the first day of the month following the month in which the Contract Amendment is executed unless otherwise specified in the amendment. Notwithstanding the above, any amendments to this Contract shall not reduce the number of Unduplicated Clients stated in EXHIBIT "B." 5.4 Identify Program Expenses Paid with OPIOID Funds. Agency will keep accounts and records in such a manner that City may readily identify and account for Program expenses reimbursed with OPIOID Funds. These records shall be made available to City for audit purposes and shall be retained as required hereunder. 5.5 Program Subcontracts. Agency shall not enter into a subcontract with another agency, contractor, or vendor to provide a service to clients for any part of the Program that will be paid with OPIOID Funds without City's written consent. 6. AGENCY CLIENTS. By entering into this Agreement, Agency promises to document and provide the following statistics and demographic data related to the clients it serves under the Agreement on a quarterly basis: date of service, service location, name or identifier number, age, gender, ethnicity and race. This information will be submitted utilizing the client data report provided by the Agency, found INTERVENTIONS OF OPIOID USE CONTRACT Page 6 The University of North Texas Health Science Center at Fort Worth attached in Exhibit "D." Agency must maintain copies of all documentation required by this Section for 5 years following the expiration of the Contract term. This Section shall survive the earlier termination or expiration of this Contract. 7. ADDITIONAL REQUIREMENTS 7.1 Agency Procurement Standards. Agency shall comply with all applicable federal, state and local laws, regulations, and ordinances for making procurements under this Contract. Agency shall not make any contract with parties listed on the government wide System for Award Management, www.sam.gov ("SAM"). Agency must confirm by search of SAM that all contractors paid with OPIOID Funds are not listed by SAM as being debarred, both prior to hiring and prior to submitting a Reimbursement Request which includes invoices from any such contractor. Failure to submit such proofs of search shall be an event of default. 7.2 Terms Applicable to Contractors, Subcontractors and Vendors. Agency understands and agrees that all terms of this Contract, whether regulatory or otherwise, shall apply to any and all contractors, subcontractors and vendors of Agency which are in any way paid with OPIOID Funds or who perform any work in connection with the Program. Agency shall cause all applicable provisions of this Contract to be included in and made a part of any contract or subcontract executed in the performance of its obligations hereunder including its obligations regarding the OPIOID Regulations. Agency shall monitor the services and work performed by its contractors, subcontractors and vendors on a regular basis for compliance with the OPIOID Term Sheet and Contract provisions. Agency must cure all violations of the OPIOID Term Sheet committed by its contractors, subcontractors or vendors. City maintains the right to insist on Agency's full compliance with the terms of this Contract and the OPIOID Term Sheet and Agency is responsible for such compliance regardless of whether actions taken to fulfill the requirements of this Contract are taken by Agency or by Agency's contractors, subcontractors or vendors. Agency acknowledges that the provisions of this Section shall survive the earlier termination or expiration of this Contract. 7.3 Conflict of Interest Disclosure. Agency shall disclose to City in writing any potential conflict of interest. 7.4 Internal Controls. In compliance with the requirements of Opioid Term Sheet, Agency shall: INTERVENTIONS OF OPIOID USE CONTRACT Page 7 The University of North Texas Health Science Center at Fort Worth 7.4.1 Establish and maintain effective internal control over the OPIOID Funds that provides reasonable assurance that Agency is managing the OPIOID Funds in compliance with state and local statutes, regulations, and the terms and conditions of this Contract. 7.4.2 Take prompt action when instances of noncompliance are identified including noncompliance identified in audit findings; and 7.4.3 Take reasonable measures to safeguard protected personally identifiable information and other information that City designates as sensitive or Agency considers sensitive consistent with applicable federal, state, local and tribal laws regarding privacy and obligations of confidentiality. 8. RECORD KEEPING; REPORTING AND DOCUMENTATION REQUIREMENTS; AUDIT. 8.1 Record Keeping. Agency shall maintain a record -keeping system as part of its performance of this Contract and shall promptly provide City with copies of any document City deems necessary for the effective fulfillment of City's monitoring and evaluation responsibilities. Specifically, Agency will keep or cause to be kept an accurate record of all actions taken and all funds spent, with supporting and back-up documentation. Agency will maintain all records and documentation related to this Contract for 5 years after the Contract term ends. If any claim, litigation, or audit is initiated before the expiration of the 5 year period, the relevant records and documentation must be retained until all such claims, litigation or audits have been resolved. 8.2 Access to Records. Representatives of City will have full access to, and the right to examine, audit, copy, excerpt and/or transcribe any of Agency's records pertaining to all matters covered by this Contract for 5 years after the Contract term ends. Such access shall be during regular business hours and upon at least 5 business days prior notice. 8.3 Change in Reporting Requirements and Forms. Any material changes to reporting requirements and forms under this Agreement shall be made effective through a bilateral amendment reflecting such change. City will notify Agency in writing at least thirty (30) days prior to the proposed effective date of any such change. 8.4 City Reserves the Right to Audit. City reserves the right to perform an audit of Agency's Program operations and finances at any time during the term of this Contract and for 5 years after the Contract term ends if City determines that such audit is necessary for City's compliance with the OPIOID Term Sheet or other City policies. Agency agrees to allow access to all pertinent materials as described herein for such audit. If such audit reveals a questioned practice or expenditure, such questions must be INTERVENTIONS OF OPIOID USE CONTRACT Page 8 The University of North Texas Health Science Center at Fort Worth resolved within 15 business days after notice to Agency of such questioned practice or expenditure. If questions are not resolved within this period, City reserves the right to withhold further funding under this Contract and/or any other contracts with Agency. IF AS A RESULT OF ANY AUDIT IT IS DETERMINED THAT AGENCY HAS FALSIFIED ANY DOCUMENTATION OR MISUSED, MISAPPLIED OR MISAPPROPRIATED OPIOID FUNDS, OR SPENT OPIOID FUNDS ON ANY INELIGIBLE ACTIVITIES, AGENCY AGREES TO REIMBURSE CITY THE AMOUNT OF SUCH MONIES PLUS THE AMOUNT OF ANY SANCTIONS, PENALTY OR OTHER CHARGE LEVIED AGAINST CITY BECAUSE OF SUCH ACTIONS TO THE EXTENT ALLOWED UNDER LAW. 9. REIMBURSEMENT REQUIREMENTS. 9.1 Deadline for Submitting Reimbursement Requests. Reimbursement Requests will be submitted quarterly to the City and must be received by the City on or before the 30th day of the month following the final month of the quarter in which expenses were paid by Agency. For example, the Reimbursement Request for the First Quarter (October 2025-December 2025) must be received by January 30, 2026. In the event the 30th falls on a weekend or City holiday, Reimbursement Requests will be due the next day that the City is open for business. Failure to submit a Reimbursement Request in a timely fashion will result in City taking the actions outlined in Section 10.1. 1st Quarter (due on January 30, 2026) 2nd Quarter (due on April 30, 2026) 3rd Quarter (due on July 30, 2026) 4th Quarter (due on October 30, 2026) October 2025 January 2026 April 2026 July 2026 November 2025 February 2026 May 2026 August 2026 December 2025 March 2026 June 2026 September 2026 9.2 Submission of Reimbursement Requests. Agency shall provide City with Complete Documentation and the following reports as attached in EXHIBIT "D" —Reimbursement Forms with each Reimbursement Request: 9.2.1 Attachment I — Request Summary (UNT Health, Fort Worth) Reimbursement Request Form). This report shall contain the amount requested for reimbursement each month of the quarter, as well as the cumulative reimbursement requested to date (inclusive of that quarter's request). 9.2.2 Attachment H — Expenditure Worksheet UNT Health, Fort Worth Payroll Report and Invoice). This report shall itemize each expense requested for reimbursement by Agency and shall include the Account corresponding the expense to a Budget line item. In order for this report to be complete the following must be submitted: INTERVENTIONS OF OPIOID USE CONTRACT Page 9 The University of North Texas Health Science Center at Fort Worth 9.2.2.1 For payroll expenses, a Payroll Report (monthly, generated from Agency's payroll system). Copies of effort reports generated from Agency's effort reporting system will be submitted bi-annually, within 30 days of the close of Agency's effort reporting cycle. 9.2.2.2 For non -payroll expenses, invoices for each expense listed with an explanation as to how the invoiced expense pertains to the Program. Agency may not submit invoices dated 60 calendar days prior to the date of the Reimbursement Request. 9.2.2.3 Proof that each expense was paid by Agency, by a General Ledger report (monthly, generated from Agency's accounting system), invoices, and receipts for each expense listed, or EFT reports for expenses paid electronically. 9.2.3 Attachment III- Client Data Report (UNT Health, Fort Worth Registration Data and Pre -posttest Survey). This report shall list each Unduplicated Client served during the month along with his or her demographic information, as described under Section 6. The Client Data Report must maintain a cumulative list of all clients served during the Contract term. 9.2.4 Delivery of Reimbursement Request. Reimbursement Requests must be submitted through Neighborly Software or other reporting software approved by the City by the deadline in Section 9.1. 10. DEFAULT AND TERMINATION. 10.1 Failure to Submit Reimbursement Request or Required Documentation. 10.1.1 To ensure compliance with the Opioid Term Sheet and city procedures, Agency will not be reimbursed for the quarter until it submits the required Reimbursement Requests and all supporting documentation described in Section 9 above. If Agency fails to submit a Reimbursement Request in accordance with Section 9, Agency is at risk of default and forfeiting payments for that quarter. 10.1.2 City will notify Agency by e-mail if a Reimbursement Request is lacking Complete Documentation or if corrections are needed. Agency will have fifteen (15) calendar days from the date of the email to submit documentation to cure the default. If proper documentation is received, Agency will receive payment for the quarter for all eligible expenses. If proper documentation is not received within fifteen (15) calendar days, City will issue a formal default notice and provide Agency with a 30-day cure period. 10.1.3 If Agency fails to submit requested information or missing documentation as set forth in Section 10.1.2, the failure to submit shall be considered an event of uncured default. INTERVENTIONS OF OPIOID USE CONTRACT Page 10 The University of North Texas Health Science Center at Fort Worth 10.1.4 In the event of an uncured default under this Section, City reserves the right to terminate this Contract effective immediately upon written notice of such intent with no penalty or liability to City. 10.1.5 In the event of termination under this Section, all OPIOID Funds awarded but unpaid to Agency pursuant to this Contract shall be immediately forfeited and Agency shall have no further right to such funds. Agency will still receive payment for all eligible expenses that were properly requested under Section 9 prior to termination under this Section. 10.2 Failure to Maintain Records or Submit Reports and Documentation. If Agency fails to maintain all records and documentation as required in Section 8, or if the maintained or submitted report or documentation is not in compliance with this Contract or the OPIOID Term Sheet, City will notify Agency in writing and Agency will have 30 calendar days from the date of the written request to obtain or recreate the missing records and documentation or submit or resubmit any such report or documentation to City. If Agency fails to maintain the required reports or documentation, or fails to submit or resubmit any such report or documentation within such time, City shall have the right to terminate this Contract effective immediately upon written notice of such intent with no penalty or liability to City. 10.3 In General. 10.3.1 Subject to Section 10.2, and unless specifically provided otherwise in this Contract, Agency shall be in default under this Contract if Agency breaches any term or condition of this Contract. In the event that such a breach remains uncured after 30 calendar days following written notice by City (or such other notice period as may be specified herein) or, if Agency has diligently and continuously attempted to cure following receipt of such written notice but reasonably requires more than 30 calendar days to cure, as determined by both Parties mutually and in good faith, City shall have the right to elect in City's sole discretion to (i) extend Agency's time to cure, (ii) terminate this Contract effective immediately upon written notice of such intent to Agency, or (iii) pursue any other legal remedies available to City under this Contract. 10.3.2 City's remedies may include: 10.3.2.1 Direct Agency to prepare and follow a schedule of actions for carrying out the affected activities, consisting of schedules, timetables and milestones necessary to implement the affected activities. 10.3.2.2 Direct Agency to establish and follow a management plan that assigns responsibilities for carrying out the remedial activities. 10.3.2.3 Reprogram OPIOID Funds that have not yet been expended from affected activities to other eligible activities or withhold OPIOID Funds. INTERVENTIONS OF OPIOID USE CONTRACT Page 11 The University of North Texas Health Science Center at Fort Worth 10.3.2.4 Any other appropriate action allowable by law. 10.4 No Compensation After Date of Termination. Agency shall not receive any compensation for work undertaken after the date of the termination. 10.5 Rights of City Not Affected. Termination shall not affect or terminate any of the existing rights of City against Agency, or which may thereafter accrue because of Agency's default and this provision shall be in addition to any and all other rights and remedies available to City under the law. Such termination does not terminate any provisions of this Contract that have been expressly noted as surviving the term or termination of the Contract. No delay or omission by City in exercising any right or remedy available to it under this Contract shall impair any such right or remedy or constitute a waiver or acquiescence in any Agency default. 10.6 Waiver of Breach Not Waiver of Subsequent Breach. The waiver of a default or breach of any term, covenant, or condition of this Contract shall not operate as a waiver of any subsequent default or breach of the same or any other term, covenant or condition hereof. 10.7 Termination for Cause. 10.7.1 City may terminate this Contract in the event of Agency's default, inability, or failure to perform subject to notice, grace and cure periods. In the event City terminates this Contract for cause, all OPIOID Funds awarded but unpaid to Agency pursuant to this Contract shall be immediately rescinded and Agency shall have no further right to such funds. AGENCY ACKNOWLEDGES AND AGREES THAT IF CITY TERMINATES THIS CONTRACT FOR CAUSE, AGENCY OR ANY AFFILIATES OF AGENCY SHALL NOT BE CONSIDERED FOR ANY OTHER CITY CONTRACT FOR OPIOID FUNDS FOR A MINIMUM OF 5 YEARS FROM THE DATE OF TERMINATION. 10.7.2 Agency may terminate this Contract if City does not provide the OPIOID Funds substantially in accordance with this Contract. 10.8 Termination for Convenience. 10.8.1 This Contract may be terminated by City with the consent of Agency in which case the Parties shall agree upon the termination conditions, including the effective date and in the case of partial termination, the portion to be terminated; or INTERVENTIONS OF OPIOID USE CONTRACT Page 12 The University of North Texas Health Science Center at Fort Worth 10.8.2 This Contract may be terminated by Agency upon at least 30 days written notification to City, the effective date, and in the case of partial termination, the portion to be terminated. In the case of a partial termination, City may terminate the Contract in its entirety if City determines in its sole discretion that the remaining portion of the Contract to be performed or OPIOID Funds to be spent will not accomplish the purposes for which the Contract was made. 10.9 Non -appropriation of Funds. In the event no funds or insufficient funds are appropriated by City in any fiscal period for any payments due hereunder, City will notify Agency of such occurrence and this Agreement shall terminate on the last day of the fiscal period for which appropriations were received without penalty or expense to City of any kind whatsoever, except as to the portions of the payments herein agreed upon for which funds have been appropriated. 11. REPAYMENT OF OPIOID FUNDS. If Agency takes any action that results in the City being required to repay all or any portion of the OPIOID Funds to the Texas Attorney General or Texas Opioid Abatement Fund Council, Agency agrees it will reimburse City within thirty days of notice from the City for such repayment. 12. SURVIVAL. Any provision of this Contract that pertains to auditing, monitoring, indemnity obligations, client income eligibility, record keeping and reports, City ordinances, or applicable OPIOID requirements, and any default and enforcement provisions necessary to enforce such provisions, shall survive the termination of this Contract for 5 years after the Contract term ends and shall be enforceable by City against Agency. 13. GENERAL PROVISIONS. 13.1 Agency an Independent Contractor. Agency shall operate hereunder as an independent contractor and not as an officer, agent, servant or employee of City. Agency shall have exclusive control of, and the exclusive right to control, the details of the work and services performed hereunder, and all persons performing same, and shall be solely responsible for the acts and omissions of its officers, members, agents, servants, employees, contractors, subcontractors, vendors, clients, licensees or invitees. 13.2 Doctrine of Respondeat Superior. The doctrine of respondeat superior shall not apply as between City and Agency, or its officers, members, agents, servants, employees, contractors, subcontractors, vendors, clients, licensees or invitees, and nothing herein shall be construed as creating a partnership or joint enterprise between City and Agency. City does not have the legal right to control the details of the tasks performed hereunder by Agency, its officers, members, agents, employees, contractors, INTERVENTIONS OF OPIOID USE CONTRACT Page 13 The University of North Texas Health Science Center at Fort Worth subcontractors, vendors, clients, licensees or invitees. 13.3 Agency Property. City shall under no circumstances be responsible for any property belonging to Agency, or its officers, members, agents, employees, contractors, subcontractors, vendors, clients, licensees or invitees that may be lost, stolen or destroyed or in any way damaged. and AGENCY, TO THE EXTENT ALLOWED UNDER LAW, HEREBY INDEMNIFIES AND HOLDS HARMLESS CITY AND ITS OFFICERS, AGENTS, AND EMPLOYEES FROM ANY AND ALL CLAIMS OR SUITS PERTAINING TO OR CONNECTED WITH SUCH PROPERTY. 13.4 Venue. Venue shall lie in state courts in Tarrant County, Texas or the United States District Court for the Northern District of Texas, Fort Worth Division for any action, whether real or asserted, at law or in equity, arising out of the execution, performance, attempted performance or non-performance of this Contract. 13.5 Governing Law. This Contract shall be governed by and construed in accordance with the laws of the State of Texas. If any action, whether real or asserted, at law or in equity, arises out of the execution, performance or non-performance of this Contract or on the basis of any provision herein, for any issue not governed by federal law, the choice of law shall be the laws of the State of Texas. 13.6 Severability. The provisions of this Contract are severable, and if for any reason a clause, sentence, paragraph or other part of this Contract shall be determined to be invalid by a court or federal or state agency, board or commission having jurisdiction over the subject matter thereof, such invalidity shall not affect other provisions which can be given effect without the invalid provision. 13.7 Written Agreement Entire Contract. This written instrument and the Exhibits, Attachments, and Addendums attached hereto, which are incorporated by reference and made a part of this Contract for all purposes, constitute the entire agreement by the Parties concerning the work and services to be performed under this Contract. Any prior or contemporaneous oral or written agreement which purports to vary the terms of this Contract shall be void. Any amendments to the terms of this Contract must be in writing and executed by the Parties. 13.8 Paragraph Headings for Reference Only, No Legal Significance; Number and Gender. The paragraph headings contained herein are for convenience in reference to this Contract INTERVENTIONS OF OPIOID USE CONTRACT Page 14 The University of North Texas Health Science Center at Fort Worth and are not intended to define or to limit the scope of any provision of this Contract. When context requires, singular nouns and pronouns include the plural and the masculine gender shall be deemed to include the feminine or neuter and the neuter gender to include the masculine and feminine. The words "include" and "including" whenever used herein shall be deemed to be followed by the words "without limitation". 13.9 Compliance With All Applicable Laws and Regulations. Agency agrees to comply fully with all applicable laws and regulations that are currently in effect or that are hereafter amended during the performance of this Contract. Those laws include, but are not limited to: • Title VI of Civil Rights Act of 1964 (42 USC 2000d et seq.) • Title VIII of Civil Rights Act of 1968 (42 USC 3601 et seq.) • The Age Discrimination in Employment Act of 1967 (29 USC et seq.). • The Age Discrimination Act of 1975 (42 USC 6101 et seq.). • Uniform Grant and Contract Management Act of 1981 • Health Insurance Portability and Accountability Act of 1996 (HIPPA) • 34 Texas Administrative Code Chapter 16, Subchapter C 13.10 Prohibition Against Discrimination. 13.10.1 General Statement. Agency may not discriminate against any person because of race, color, sex, gender, religion, national origin, familial status, disability or perceived disability, sexual orientation, gender identity, gender expression, or transgender, nor will Agency permit its officers, members, agents, employees, or clients to engage in such discrimination. 13.10.2 Agency's Contractors and the ADA. In accordance with the provisions of the Americans With Disabilities Act of 1990 ("ADA"), Agency certifies that it and any of its contractors will not unlawfully discriminate on the basis of disability in the provision of services to the general public, nor in the availability, terms and/or conditions of employment for applicants for employment with, or employees of, Agency or any of its contractors. AGENCY CERTIFIES IT WILL FULLY COMPLY WITH THE ADA'S PROVISIONS AND ANY OTHER APPLICABLE FEDERAL, STATE AND LOCAL LAWS CONCERNING DISABILITY AND, TO THE EXTENT ALLOWED UNDER LAW, WILL DEFEND, INDEMNIFY AND HOLD CITY HARMLESS AGAINST ANY CLAIMS OR ALLEGATIONS ASSERTED BY THIRD PARTIES, CONTRACTORS SUBCONTRACTORS, VENDORS OR AGENTS AGAINST CITY ARISING OUT OF AGENCY'S AND/OR ITS CONTRACTORS', SUBCONTRACTORS', VENDORS' OR AGENTS' OR THEIR RESPECTIVE EMPLOYEES' ALLEGED FAILURE TO COMPLY WITH THE ABOVE -REFERENCED LAWS CONCERNING DISABILITY DISCRIMINATION IN THE PERFORMANCE OF THIS CONTRACT. INTERVENTIONS OF OPIOID USE CONTRACT Page 15 The University of North Texas Health Science Center at Fort Worth 13.11 Agency Safeguards. Agency shall establish safeguards to prohibit its employees, board members, advisors and agents from using positions for a purpose that is or gives the appearance of being motivated by a desire for private gain for themselves or others, particularly those with whom they have family, business or other ties. Agency shall disclose to City any such conflict of interest or potential conflict of interest, immediately upon discovery of such. 13.12 General Prohibitions Against Conflicts of Interest. No employees, agents, consultants, officers or elected officials or appointed officials of City or of Agency who exercise or have exercised any functions or responsibilities with respect to activities assisted with OPIOID funds or who are in a position to participate in a decision -making process or gain inside information with regard to these activities may utilize OPIOID services, may obtain a financial interest or benefit from a OPIOID-assisted activity, or have an interest in any contract, subcontract or agreement with respect thereto, or the proceeds thereunder, either for themselves or those with whom they have family or business ties, during their tenure or for 1 year thereafter. Agency shall establish conflict of interest policies for state awards including the OPIOID Funds and shall disclose in writing potential conflicts of interest to City. 13.13 Other Laws. The failure to list any federal, state or City ordinance, law or regulation that is applicable to Agency does not excuse or relieve Agency from the requirements or responsibilities in regard to following the law, nor from the consequences or penalties for Agency's failure to follow the law, if applicable. 13.14 Assignment. Agency shall not assign all or any part of its rights, privileges, or duties under this Contract without the prior written approval of City. Any attempted assignment of same without approval shall be void, and shall constitute a breach of this Contract. 13.15. Right to Inspect Agency Contracts. It is agreed that City has the right to inspect and approve in writing any proposed contracts between Agency and any contractor or vendor engaged in activity directly related with this OPIOID-funded Program prior to any charges being incurred. 13.16 Force Maieure. If Agency becomes unable, either in whole or part, to fulfill its obligations under this Contract due to acts of God, strikes, lockouts, or other industrial disturbances, acts of public enemies, wars, blockades, insurrections, riots, epidemics, pandemics, earthquakes, fires, floods, restraints or prohibitions by any court, board, department, commission or agency of the United INTERVENTIONS OF OPIOID USE CONTRACT Page 16 The University of North Texas Health Science Center at Fort Worth States or of any States, civil disturbances, or explosions, or some other reason beyond Agency's control (collectively, "Force Majeure Event"), the obligations so affected by such Force Majeure Event will be suspended only during the continuance of such event. Agency will give City written notice of the existence, extent and nature of the Force Majeure Event as soon as reasonably possible after the occurrence of the event. Failure to give notice will result in the continuance of Agency's obligation regardless of the extent of any existing Force Majeure Event. Agency will use commercially reasonable efforts to remedy its inability to perform as soon as possible. 13.17 IMMIGRATION NATIONALITY ACT. Agency shall verify the identity and employment eligibility of its employees who perform work under this Contract, including completing the Employment Eligibility Verification Form (I- 9). Upon request by City, Agency shall provide City with copies of all I-9 forms and supporting eligibility documentation for each employee who performs work under this Contract. Agency shall adhere to all Federal and State laws as well as establish appropriate procedures and controls so that no services will be performed by any Agency employee who is not legally eligible to perform such services. TO THE EXTENT ALLOWED UNDER LAW, AGENCY SHALL INDEMNIFY CITY AND HOLD CITY HARMLESS FROM ANY PENALTIES, LIABILITIES, OR LOSSES DUE TO VIOLATIONS OF THIS PARAGRAPH BY AGENCY, AGENCY'S EMPLOYEES, SUBCONTRACTORS, AGENTS, OR LICENSEES. City, upon written notice to Agency, shall have the right to immediately terminate this Contract for violations of this provision by Agency. 14. INDEMNIFICATION AND RELEASE. Agency shall, to the extent authorized under the Constitution and laws of the State of Texas, indemnify and hold City harmless from liability resulting from the negligent acts or omissions of Agency, its agents, contractors, subcontractors, or employees pertaining to the activities to be carried out pursuant to the obligations of this Agreement; provided, however, that Agency shall not hold City harmless from claims arising out of the gross negligence or willful malfeasance of City, its officers, agents, or employees.. 15. IMMUNITY BY AGENCY. The parties acknowledge that Agency is an agency of the State of Texas and under the Constitution and laws of the State of Texas possesses certain rights and privileges, is subject to certain limitations and restrictions, and only has such authority as is granted under the Constitution and laws of the State of Texas. Notwithstanding any provision hereof, nothing in this Agreement is intended to be, nor will it be construed to be, a waiver of the sovereign immunity of the State of Texas or a prospective waiver or restriction of any of the rights, remedies, claims, and privileges of the State of Texas. The parties acknowledge that this Agreement does not constitute consent by the State of Texas to be sued in any lawsuit, but does reflect its intent to be bound by the terms of this Agreement to the full extent authorized by the Constitution and laws of the State of Texas. Moreover, notwithstanding the generality or specificity of any provision hereof, the provisions of this agreement as they pertain to Agency are enforceable to the full extent authorized by the Constitution and laws of the State of Texas; accordingly, to the extent any provision hereof INTERVENTIONS OF OPIOID USE CONTRACT Page 17 The University of North Texas Health Science Center at Fort Worth conflicts with the Constitution or laws of the State of Texas or exceeds the right, power or authority of Agency to agree to such, such provision will not be enforceable against Agency or the State of Texas. 16. INSURANCE AND BONDING. Agency is an agency of the State of Texas and is self -insured for general liability. Limits of liability are governed by the Texas Tort Claims Act, Tex. Civ. Prac. & Rem. Code § 101 and State Liability for Conduct of Public Servants, Tex. Civ. Prac. & Rem. Code § 104. Agency will maintain Workers Compensation insurance in the amounts required by state and federal law. 17. LITIGATION AND CLAIMS. Agency shall give City prompt notice in writing of any action, including any proceeding before an administrative agency, filed against Agency in conjunction with this Contract or the Program. Agency shall furnish promptly to City copies of all pertinent papers received by Agency with respect to such action or claim. Agency shall provide a notice to City within 30 days upon filing under any bankruptcy or financial insolvency provision of law. 18. NOTICE. All notices required or permitted by this Contract must be in writing and are deemed delivered on the earlier date of the date actually received or the third day following deposit in a United States Postal Service post office or receptacle; with proper postage, certified mail return receipt requested; and addressed to the other Party at the address set out below or at such other address as the receiving Party designates by proper notice to the sending Party. City: City Attorney's Office 100 Fort Worth Trail Fort Worth, TX 76102 Telephone : 817-392-7600 Copy to: Neighborhood Services Department 100 Fort Worth Trail Fort Worth, TX 76102 Attention: Kacey Thomas Telephone: 817-3 92-7 540 Copy to: Neighborhood Services Department 100 Fort Worth Trail Fort Worth, TX 76102 Attention: Mary Tenorio Telephone: 817-3 92-643 2 INTERVENTIONS OF OPIOID USE CONTRACT Page 18 The University of North Texas Health Science Center at Fort Worth Agency: UNT Health, Fort Worth Office of Sponsored Programs 3500 Camp Bowie Blvd. Fort Worth, TX 76107 Telephone: 817-735-5073 19. AGENCY HAS LEGAL AUTHORITY TO ENTER INTO CONTRACT. Agency represents that it possesses the legal authority, pursuant to any proper, appropriate and official motion, resolution or action passed or taken, to enter into this Contract and to perform the responsibilities herein required. 20. COUNTERPARTS. This Contract may be executed in multiple counterparts, each of which shall be considered an original, but all of which shall constitute one instrument which may be sufficiently evidenced by one counterpart. 21. PROHIBITION ON CONTRACTING WITH COMPANIES THAT BOYCOTT ISRAEL If Agency has less than ten employees, this contract is for less than $100,000, or Agency does not meet the definition of a "company" under the applicable section of the Texas Government Code, this provision shall not apply. Agency acknowledges that in accordance with Chapter 2270 of the Texas Government Code, the City is prohibited from entering into a contract with a company for goods or services unless the contract contains a written verification from the company that it: (1) does not boycott Israel; and (2) will not boycott Israel during the term of the contract. The terms "boycott Israel" and "company" shall have the meanings ascribed to those terms in Section 808.001 of the Texas Government Code. By signing this contract, Agency certifies that Agency's signature provides written verification to the City that Agency: (1) does not boycott Israel; and (2) will not boycott Israel during the term of the contract. 22. PROHIBITION ON BOYCOTTING ENERGY COMPANIES Agency acknowledges that in accordance with Chapter 2276 of the Texas Government Code, City is prohibited from entering into a contract for goods or services that has a value of $100,000 or more that is to be paid wholly or partly from public funds of the City with a company with 10 or more full-time employees unless the contract contains a written verification from the company that it: (1) does not boycott energy companies; and (2) will not boycott energy companies during the term of the contract. To the extent that Chapter 2276 of the Government Code is applicable to this Agreement, by signing this Agreement, Agency certifies that Agency's signature provides written verification to the City that Agency: (1) does not boycott energy companies; and (2) will not boycott energy companies during the term of this Agreement. 23. PROHIBITION ON DISCRIMINATION AGAINST FIREARM AND AMMUNITION INDUSTRIES INTERVENTIONS OF OPIOID USE CONTRACT Page 19 The University of North Texas Health Science Center at Fort Worth Agency acknowledges that except as otherwise provided by Chapter 2274 of the Texas Government Code, City is prohibited from entering into a contract for goods or services that has a value of $100,000 or more that is to be paid wholly or partly from public funds of the City with a company with 10 or more full-time employees unless the contract contains a written verification from the company that it: (1) does not have a practice, policy, guidance, or directive that discriminates against a firearm entity or firearm trade association; and (2) will not discriminate during the term of the contract against a firearm entity or firearm trade association. To the extent that Chapter 2274 of the Government Code is applicable to this Agreement, by signing this Agreement, Agency certifies that Agency's signature provides written verification to the City that Agency: (1) does not have a practice, policy, guidance, or directive that discriminates against a firearm entity or firearm trade association; and (2) will not discriminate against a firearm entity or firearm trade association during the term of this Agreement. [SIGNATURES APPEAR ON NEXT PAGE] INTERVENTIONS OF OPIOID USE CONTRACT Page 20 The University of North Texas Health Science Center at Fort Worth IN WITNESS WHEREOF, the Parties hereto have executed this Contract: ATTEST: Jannette Goodall City Secretary M&C: 25-0586 Date: June 24, 2025 1295 Certification No. 2025-1286417 RECOMMENDED BY: mctpi OlvomoV Kacey Thomas (Sep 29, 202513:50:22 CDT) Kacey Thomas Neighborhood Services Director APPROVED AS TO FORM AND LEGALITY: Sophie Mathews Sophie Mathews Assistant City Attorney CITY OF FORT WORTH: Dana Burgh doff (Oct 3, 202511,37:0 T) Dana Burghdoff Assistant City Manager CONTRACT COMPLIANCE ADMINISTRATOR: By signing, I acknowledge that I am the person responsible for the monitoring and administration of this contract, including ensuring all performance and reporting requirements. Y/G.&23! Lu c Mary Tenorio Neighborhood Development Specialist UNT HEALTH, FORT WORTH Authorized Official: By signing, I acknowledge that I am the duly authorized representative. INTERVENTIONS OF OPIOID USE CONTRACT Page 21 The University of North Texas Health Science Center at Fort Worth OFFICIAL RECORD CITY SECRETARY FT. WORTH, TX ��l,,.ealL ,Pe6o�td Myriah Roberts, J.D., Director, Research Agreements Read and Understood: io.2.oa.. GC)1#14.4. Teresa Wagner, DrPH, MS, CPH, RD/LD, CPPS, CHWI, DipACLM, CHWC INTERVENTIONS OF OPIOID USE CONTRACT Page 22 The University of North Texas Health Science Center at Fort Worth OFFICIAL RECORD CITY SECRETARY FT. WORTH, TX EXHIBIT LIST EXHIBIT "A" -Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet EXHIBIT "B" —Program Summary EXHIBIT "C" — Budget EXHIBIT "D" — Reimbursement Forms (UNT Health, Fort Worth Forms for Reimbursement Request) EXHIBIT "E" — Texas Opioid Abatement Fund Council and Settlement Allocation: List of Opioid Remediation Uses EXHIBIT "F" — Standards for Complete Documentation INTERVENTIONS OF OPIOID USE CONTRACT Page 23 The University of North Texas Health Science Center at Fort Worth City of Fort Worth TEXAS OPIOID ABATEMENT FUND COUNCIL AND SETTLEMENT ALLOCATION TERM SHEET EXHIBIT A WHEREAS, the people of the State of Texas and its communities have been harmed through the National and Statewide epidemic caused by licit and illicit opioid use and distribution within the State of Texas; and now, WHEREAS, the State of Texas, though its elected representatives and counsel, including the Honorable Ken Paxton, Attorney General of the State of Texas, and certain Political Subdivisions, through their elected representatives and counsel, are separately engaged in litigation seeking to hold those entities in the supply chain accountable for the damage caused; and now, WHEREAS, the State of Texas, through its Attorney General and its Political Subdivisions, share a common desire to abate and alleviate the impacts of the epidemic throughout the State of Texas; and now, THEREFORE, the State of Texas and its Political Subdivisions, subject to completing formal documents effectuating the Parties' agreements, enter into this State of Texas and Texas Political Subdivisions' Opioid Abatement Fund Council and Settlement Allocation Term Sheet (Texas Term Sheet) relating to the allocation and use of the proceeds of any Settlements as described. A. Definitions As used in this Texas Term Sheet: 1 1. "The State" shall mean the State of Texas acting through its Attorney General. 2. "Political Subdivision(s)" shall mean any Texas municipality and county. 3. "The Parties" shall mean the State of Texas, the Political Subdivisions, and the Plaintiffs' Steering Committee and Liaison Counsel (PSC) in the Texas Opioid MDL, In Re: Texas Opioid Litigation, MDL No. 2018-63587, in the 152d District Court of Harris County, Texas. 4. "Litigating Political Subdivision" means a Political Subdivision that filed suit in the state courts of the State of Texas prior to the Execution Date of this Agreement, whether or not such case was transferred to Texas Opioid MDL, or removed to federal court. 5. "National Fund" shall mean any national fund established for the benefit of the Texas Political Subdivisions. In no event shall any National Fund be used to create federal jurisdiction, equitable or otherwise, over the Texas Political Subdivisions or those similarly situated state -court litigants who are included in the state coalition, nor shall the National Fund require participating in a class action or signing a participation agreement as part of the criteria for participating in the National Fund. 6. "Negotiating Committee" shall mean a three -member group comprising four representatives for each of (1) the State; (2) the PSC; and (3) Texas' 2 Political Subdivisions (collectively, "Members"). The State shall be represented by the Texas Attorney General or his designees. The PSC shall be represented by attorneys Mikal Watts, Jeffrey Simon, Dara Hegar, Dan Downey, or their designees. Texas' Political Subdivisions shall be represented by Clay Jenkins (Dallas County Judge), Terrence O'Rourke (Special Assistant County Attorney, Harris County), Nelson Wolff (Bexar County Judge), and Nathaniel Moran (Smith County Judge) or their designees. 7. "Settlement" shall mean the negotiated resolution of legal or equitable claims against a Pharmaceutical Supply Chain Participant that includes the State and Political Subdivisions. 8. "Opioid Funds" shall mean monetary amounts obtained through a Settlement as defined in this Texas Term Sheet. 8. "Approved Purpose(s)" shall mean those uses identified in Exhibit A hereto. 9. "Pharmaceutical Supply Chain" shall mean the process and channels through which opioids or opioids products are manufactured, marketed, promoted, distributed, or dispensed. 3 10."Pharmaceutical Supply Chain Participant" shall mean any entity that engages in or has engaged in the manufacture, marketing, promotion, distribution, or dispensing of an opioid analgesic. 11. "Texas Opioid Council" shall mean the Council described in Exhibit A hereto, which has the purpose of ensuring the funds recovered by Texas (through the joint actions of the Attorney General and the Texas Political Subdivisions) are allocated fairly and spent to remediate the opioid crisis in Texas, using efficient and cost-effective methods that are directed to the hardest hit regions in Texas while also ensuring that all Texans benefit from prevention and recovery efforts. B. Allocation of Settlement Proceeds 1. All Opioid Funds distributed in Texas shall be divided with 15% going to Political Subdivisions ("Subdivision Share"), 70% to the Texas Opioid Abatement Fund through the Texas Opioid Council (Texas Abatement Fund Share) identified and described on Exhibits A and C hereto, and 15% to the Office of the Texas Attorney General as Counsel for the State of Texas ("State Share"). Out of the Texas Opioid Abatement Fund, reasonable expenses up to 1 % shall be paid to the Texas Comptroller for the administration of the Texas Opioid Council pursuant to the Opioid 4 Abatement Fund (Texas Settlement) Opioid Council Agreement, Exhibit A hereto. 2. The Subdivisions Share shall be allocated in accordance with the division of proceeds on Exhibit B hereto. 3. The Texas Abatement Fund Share shall be allocated to the Opioid Council to be apportioned in accordance with the guidelines of Exhibit A, and Exhibit C hereto. 4. In the event a Subdivision merges, dissolves, or ceases to exist, the allocation percentage for that Subdivision shall be redistributed as directed by the settlement document, and if not specified, equitably based on the composition of the successor Subdivision. If a Subdivision for any reason is excluded from a specific settlement, the allocation percentage for that Subdivision shall be redistributed as directed by the settlement document, and if not specified, equitably among the participating Subdivisions. 5. Funds obtained from parties unrelated to the Litigation, via grant, bequest, gift or the like, separate and distinct from the Litigation, may be directed to the Texas Opioid Council and disbursed as set forth below. 6. The Subdivision share shall be initially deposited and paid in cash directly to the Subdivision under the authority and guidance of the Texas MDL Court, who shall direct any Settlement funds to be held in trust in a 5 segregated account to benefit the Subdivisions and to be promptly distributed as set forth herein and in accordance with Exhibit B. 7. Nothing in this Texas Term Sheet should alter or change any Subdivision's rights to pursue its own claim. Rather, the intent of this Texas Term Sheet is to join all parties to disburse settlement proceeds from one or more defendants to all parties participating in that settlement within Texas. 8. Opioid Funds from the Texas Abatement Fund Share shall be directed to the Texas Opioid Council and used in accordance with the guidelines as set out on Exhibit A hereto, and the Texas Abatement Fund Share shall be distributed to the Texas Opioid Council under the authority and guidance of the Texas MDL Court, consistent with Exhibits A and C, and the by- laws of the Texas Opioid Council documents and disbursed as set forth therein, including without limitation all abatement funds and the 1 % holdback for expenses. 9. The State of Texas and the Political Subdivisions understand and acknowledge that additional steps may need to be undertaken to assist the Texas Opioid Council in its mission, at a predictable level of funding, regardless of external factors. C. Payment of Counsel and Litigation Expenses 6 1. Any Master Settlement Agreement settlement will govern the payment of fees and litigation expenses to the Parties. The Parties agree to direct control of any Texas Political Subdivision fees and expenses to the "Texas Opioid Fee and Expense Fund," which shall be allocated and distributed by the Texas MDL Court, In re: Texas Opioid Litigation, MDL No. 2018- 63587, in the 152nd District Court of Harris County, Texas, and with the intent to compensate all counsel for Texas Political Subdivisions who have not chosen to otherwise seek compensation for fees and expenses from any federal MDL common benefit fund. 2. The Parties agree that no portion of the State of Texas 15% allocation share from any settlement shall be administered through the National Fund, the Texas MDL Court, or Texas Opioid Fee and Expense Fund, but shall be directed for payment to the State of Texas by the State of Texas. 3. The State of Texas and the Texas Political Subdivisions, and their respective attorneys, agree that all fees — whether contingent, hourly, fixed or otherwise — owed by the Texas Political Subdivisions shall be paid out of the National Fund or as otherwise provided for herein to the Texas Opioid Fee and Expense Fund to be distributed by the 152nd District Court of Harris County, Texas pursuant to its past and future orders. 4. From any opioid-related settlements with McKesson, Cardinal Health, ABDC, and Johnson & Johnson, and for any future opioid-related settlements negotiated, in whole or in part, by the Negotiating Committee with any other Pharmaceutical Supply Chain Participant, the funds to be deposited in the Texas Opioid Fee and Expense Fund shall be 9.3925% of the combined Texas Political Subdivision and Texas Abatement Fund portions of each payment (annual or otherwise) to the State of Texas for that settlement, plus expenses from the National Fund, and shall be sought by Texas Political Subdivision Counsel initially through the National Fund. The Texas Political Subdivisions' percentage share of fees and expenses from the National Fund shall be directed to the Texas Opioid Fee and Expense Fund in the Texas MDL, as soon as is practical, for allocation and distribution in accordance with the guidelines herein. 5. If the National Fund share to the Texas Political Subdivisions is insufficient to cover the guaranteed 9.3925%, plus expenses from the National Fund, per subsection 4, immediately supra, or if payment from the National Fund is not received within 12 months after the date the 8 first payment is made by the Defendants pursuant to the settlement, then the Texas Political Subdivisions shall recover up to 12.5% of the Texas Political Subdivision Share to make up any difference. 6. If the National Fund and the Texas Political Subdivision share are insufficient to cover the guaranteed 9.3925%, plus expenses from the National Fund, or if payment from the National Fund is not received within 12 months after the date the first payment is made by the Defendants pursuant to the settlement, then the Texas Political Subdivisions shall recover up to 8.75% of the Abatement Fund Share to make up any difference. In no event shall the Texas Political Subdivision share exceed 9.3925% of the combined Texas Political Subdivision and Texas Abatement Fund portions of any settlement, plus expenses from the National Fund. In the event that any payment is received from the National Fund such that the total amount in fees and expenses exceeds 9.3925%, the Texas Political Subdivisions shall return any amounts received greater than 9.3925% of the combined Texas Political Subdivision and Texas Abatement Fund portions to those respective Funds. 9 7. For each settlement utilizing a National Fund, the Texas Political Subdivisions need only make one attempt at seeking fees and expenses there. 8. The total amount of the Texas Opioid Fee and Expense Fund shall be reduced proportionally, according to the agreed upon allocation of the Texas Subdivision Fund, for any Texas litigating Political Subdivision that (1) fails to enter the settlement; and (2) was filed in Texas state court, and was transferred to the Texas MDL (or removed before or during transfer to the Texas MDL) as of the execution date of this Agreement. D. The Texas Opioid Council and Texas Abatement Fund The Texas Opioid Council and Texas Abatement Fund is described in detail at Exhibit A, incorporated herein by reference. E. Settlement Negotiations 1. The State and Negotiating Committee agree to inform each other in advance of any negotiations relating to a Texas -only settlement with a Pharmaceutical Supply Chain Participant that includes both the State and its Political Subdivisions and shall provide each other the opportunity to participate in all such negotiations. Any Texas -only Settlement agreed to with the State and Negotiating Committee shall be subject to the approval 10 of a majority of litigating Political Subdivisions. The Parties further agree to keep each other reasonably informed of all other global settlement negotiations with Pharmaceutical Supply Chain Participants and to include the Negotiating Committee or designees. Neither this provision, nor any other, shall be construed to state or imply that either the State or the Negotiating Committee is unauthorized to engage in settlement negotiations with Pharmaceutical Supply Chain Participants without prior consent or contemporaneous participation of the other, or that either party is entitled to participate as an active or direct participant in settlement negotiations with the other. Rather, while the State's and Negotiation Committee's efforts to achieve worthwhile settlements are to be collaborative, incremental stages need not be so. 2. Any Master Settlement Agreement (MSA) shall be subject to the approval and jurisdiction of the Texas MDL Court. 3. As this is a Texas -specific effort, the Committee shall be Chaired by the Attorney General. However, the Attorney General, or his designees, shall endeavor to coordinate any publicity or other efforts to speak publicly with the other Committee Members. 4. The State of Texas, the Texas MDL Plaintiff's Steering Committee representatives, or the Political Subdivision representatives may withdraw 11 from coordinated Settlement discussions detailed in this Section upon 10 business days' written notice to the remaining Committee Members and counsel for any affected Pharmaceutical Supply Chain Participant. The withdrawal of any Member releases the remaining Committee Members from the restrictions and obligations in this Section. 5. The obligations in this Section shall not affect any Party's right to proceed with trial or, within 30 days of the date upon which a trial involving that Party's claims against a specific Pharmaceutical Supply Chain Participant is scheduled to begin, reach a case specific resolution with that particular Pharmaceutical Supply Chain Participant. F. Amendments The Parties agree to make such amendments as necessary to implement the intent of this agreement. Acknowledgment of Agreement We, the undersigned, have participated in the drafting of the above Texas Term Sheet, including consideration based on comments solicited from Political Subdivisions. This document has been collaboratively drafted to maintain all individual claims while allowing the State and its Political Subdivisions to cooperate in exploring all possible means of resolution. Nothing in this agreement binds any party to any specific outcome. Any resolution under this document will require 12 acceptance by the State of Texas and a majority of the Litigating Political Subdivisions. We, the undersigned, hereby accept the STATE OF TEXAS AND TEXAS POLITICAL SUBDIVISIONS' OPIOID ABATEMENT FUND COUNCIL AND SETTLEMENT ALLOCATION TERM SHEET. We understand that the purpose of this Texas Term Sheet is to permit collaboration between the State of Texas and Political Subdivisions to explore and potentially effectuate earlier resolution of the Opioid Litigation against Pharmaceutical Supply Chain Participants. We also understand that an additional purpose is to create an effective means of distributing any potential settlement funds obtained under this Texas Term Sheet between the State of Texas and Political Subdivisions in a manner and means that would promote an effective and meaningful use of the funds in abating the opioid epidemic throughout Texas. 13 Executed this 13 day of May, 2020. FOR THE STATE OF TEXAS: .,20.4&sk_ KENNETH PAXTON, JR. ATTORNEY GENERAL FOR THE SUBDIVISIONS AND TEXAS MDL PSC: 9scia14f.- MIKAL WATTS WATTS GUERRA LLP ItE Y G!N ENST EN T SIMON ONE PANATIER, PC P.-Dia/kik-4E4r DARA HEGAR :sas EXHIBIT A Opioid Abatement Fund (Texas) Settlement Opioid Council As part of the settlement agreement and upon its execution, the parties will form the Texas Opioid Council (Council) to establish the framework that ensures the funds recovered by Texas (through the joint actions of the Attorney General and the state's political subdivisions) are allocated fairly and spent to remediate the opioid crisis in Texas, using efficient and cost-effective methods that are directed to the hardest hit regions in Texas while also ensuring that all Texans benefit from prevention and recovery efforts. I. Structure The Council will be responsible for the processes and procedures governing the spending of the funds held in the Texas Abatement Fund, which will be approximately 70% of all funds obtained through settlement and/or litigation of the claims asserted by the State and its subdivisions in the investigations and litigation related to the manufacturing, marketing, distribution, and sale of opioids and related pharmaceuticals. Money paid into the abatement fund will be held by an independent administrator, who shall be responsible for the ministerial task of releasing funds solely as authorized below by the Council, and accounting for all payments to and from the fund. The Council will be formed when a court of competent jurisdiction enters an order settling the matter, including any order of a bankruptcy court. The Council's members must be appointed within sixty (60) days of the date the order is entered. A Membership The Council shall be comprised of the following thirteen (13) members: 1. Statewide Members. Six members appointed by the Governor and Attorney General to represent the State's interest in opioid abatement. The statewide members are appointed as follows: a. The Governor shall appoint three (3) members who are licensed health professionals with significant experience in opioid interventions; b. The Attorney General shall appoint three (3) members who are licensed professionals with significant experience in opioid incidences; and c. The Governor will appoint the Chair of the Council as a non -voting member. The Chair may only cast a vote in the event there is a tie of the membership. 2. Regional Members. Six (6) members appointed by the State's political subdivisions to represent their designated Texas Health and Human Services Commission "HHSC" Regional Healthcare 1 Partnership (Regions) to ensure dedicated regional, urban, and rural representation on the Council. The regional appointees must be from either academia or the medical profession with significant experience in opioid interventions. The regional members are appointed as follows: a. One member representing Regions 9 and 10 (Dallas Ft -Worth); b. One member representing Region 3 (Houston); c. One member representing Regions 11, 12, 13, 14, 15, 19 (West Texas); d. One member representing Regions 6, 7, 8, 16 (Austin -San Antonio); e. One member representing Regions 1, 2, 17, 18 (East Texas); and f. One member representing Regions 4, 5, 20 (South Texas). B Terms All members of the Council are appointed to serve staggered two-year terms, with the terms of members expiring February 1 of each year. A member may serve no more than two consecutive terms, for a total of four consecutive years. For the first term, four (4) members (two (2) statewide and two (2) for the subdivisions) will serve a three-year term. A vacancy on the Council shall be filled for the unexpired term in the same manner as the original appointment. The Governor will appoint the Chair of the Council who will not vote on Council business unless there is a tie vote, and the subdivisions will appoint a Vice -Chair voting member from one of the regional members. C Governance 1. Administration The Council is attached administratively to the Comptroller. The Council is an independent, quasi -governmental agency because it is responsible for the statewide distribution of the abatement settlement funds. The Council is exempt from the following statutes: a. Chapter 316 of the Government Code (Appropriations); b. Chapter 322 of the Government Code (Legislative Budget Board); c. Chapter 325 of the Government Code (Sunset); d. Chapter 783 of the Government Code (Uniform Grants and Contract Management); e. Chapter 2001 of the Government Code (Administrative Procedure); f. Chapter 2052 of the Government Code (State Agency Reports and Publications); g. Chapter 2261 of the Government Code (State Contracting Standards and Oversight); h. Chapter 2262 of the Government Code (Statewide Contract Management); 2 i. Chapter 262 of the Local Government Code (Purchasing and Contracting Authority of Counties); and j. Chapter 271 of the Local Government Code (Purchasing and Contracting Authority of Municipalities, Counties, and Certain Other Local Governments). 2. Transparency The Council will abide by state laws relating to open meetings and public information, including Chapters 551 and 552 of the Texas Government Code. i. The Council shall hold at least four regular meetings each year. The Council may hold additional meetings on the request of the Chair or on the written request of three members of the council. All meetings shall be open to the public, and public notice of meetings shall be given as required by state law. ii. The Council may convene in a closed, non-public meeting: a. If the Commission must discuss: 1. Negotiation of contract awards; and 2. Matters specifically exempted from disclosure by federal and state statutes. b. All minutes and documents of a closed meeting shall remain under seal, subject to release only order of a court of competent jurisdiction. 3. Authority The Council does not have rulemaking authority. The terms of each Judgment, Master Settlement Agreement, or any Bankruptcy Settlement for Texas control the authority of the Council and the Council may not stray outside the bounds of the authority and power vested by such settlements. Should the Council require legal assistance in determining their authority, the Council may direct the executive director to seek legal advice from the Attorney General to clarify the issue. D Operation and Expenses The independent administrator will set aside up to one (1) percent of the settlement funds for the administration of the Council for reasonable costs and expenses of operating the foregoing duties, including educational activities. 1. Executive Director The Comptroller will employ the executive director of the Council and other personnel as necessary to administer the duties of the Council and carry out the functions of the Council. The executive director must have at least 10 years of experience in government or public administration and is classified as a Director VB30 under the State Auditor's State Classification. The Comptroller will pay the salaries of the Council employees from the 3 one (1) percent of the settlement funds set aside for the administration of the Council. The Comptroller will request funds from the Texas Abatement Fund Point of Contact. 2. Travel Reimbursement A person appointed to the Council is entitled to reimbursement for the travel expenses incurred in attending Council duties. A member of the Council may be reimbursed for actual expenses for meals, lodging, transportation, and incidental expenses in accordance with travel rates set by the federal General Services Administration. II. Duties/Roles It is the duty of the Council to determine and approve the opioid abatement strategies and funding awards. A. Approved Abatement Strategies The Council will develop the approved Texas list of abatement strategies based on but not limited to the existing national list of opioid abatement strategies (see attached Appendix A) for implementing the Texas Abatement Fund. 1. The Council shall only approve strategies which are evidence -informed strategies. 2. The Texas list of abatement strategies must be approved by majority vote. The majority vote must include a majority from both sides of the statewide members and regional members in order to be approved, e.g., at least four (4) of six (6) members on each side. B Texas Abatement Fund Point of Contact The Council will determine a single point of contact called the Abatement Fund Point of Contact (POC) to be established as the sole entity authorized to receive requests for funds and approve expenditures in Texas and order the release of funds from the Texas Abatement Fund by the independent administrator. The POC may be an independent third party selected by the Council with expertise in banking or financial management. The POC will manage the Opioid Council Bank Account (Account). Upon a vote, the Council will direct the POC to contact the independent administrator to release funds to the Account. The Account is outside the State Treasury and not managed by any state or local officials. The POC is responsible for payments to the qualified entities selected by the Council for abatement fund awards. The POC will submit a monthly financial statement on the Account to the Council. C Auditor An independent auditor appointed by the Council will perform an audit on the Account on an annual basis and report its findings, if any, to the Council. D Funding Allocation 4 The Council is the sole decision -maker on the funding allocation process of the abatement funds. The Council will develop the application and award process based on the parameters outlined below. An entity seeking funds from the Council must apply for funds; no funds will be awarded without an application. The executive director and personnel may assist the Council in gathering and compiling the applications for consideration; however, the Council members are the sole decision -makers of awards and funding determination. The Council will use the following processes to award funds: 1. Statewide Funds. The Council will consider, adopt and approve the allocation methodology attached as Exhibit C, based upon population health data and prevalence of opioid incidences, at the Council's initial meeting. Adoption of such methodology will allow each Region to customize the approved abatement strategies to fit its communities' needs. The statewide regional funds will account for seventy-five (75) percent of the total overall funds, less the one (1) percent administrative expense described herein. 2. Targeted Funds. Each Region shall reserve twenty-five (25) percent of the overall funds, for targeted interventions in the specific Region as identified by opioid incidence data. The Council must approve on an annual basis the uses for the targeted abatement strategies and applications available to every Region, including education and outreach programs. Each Region without approved uses for the targeted funds from the Council, based upon a greater percentage of opioid incidents compared to its population, is subject to transfer of all or a portion of the targeted funds for that Region for uses based upon all Regions' targeted funding needs as approved by the Council on an annual basis. 3. Annual Allocation. Statewide regional funds and targeted funds will be allocated on an annual basis. If a Region lapses its funds, the funds will be reallocated based on all Regions' funding needs. E Appeal Process The Council will establish an appeal process to permit the applicants for funding (state or subdivisions) to challenge decisions by the Council -designated point of contact on requests for funds or expenditures. 1. To challenge a decision by the designated point of contact, the State or a subdivision must file an appeal with the Council within thirty (30) days of the decision. The Council then has thirty (30) days to consider and rule on the appeal. 2. If the Council denies the appeal, the party may file an appeal with the state district court of record where the final opioid judgment or Master Settlement Agreement is filed. The Texas Rules of Civil Procedure and Rules of Evidence will govern these proceedings. The Council may request representation from the Attorney General in these proceedings. 5 In making its determination, the state district court shall apply the same clear error standards contained herein that the Council must follow when rendering its decision. 3. The state district court will make the fmal decision and the decision is not appealable. 4. Challenges will be limited and subject to penalty if abused. 5. Attorneys' fees and costs are not recoverable in these appeals. F Education The Council may determine that a percentage of the funds in the Abatement Fund from the targeted funds be used to develop an education and outreach program to provide materials on the consequences of opioid drug use, prevention and interventions. Any material developed will include online resources and toolkits for communities. 6 EXHIBIT B Exhibit B: Municipal Area Allocations: 15% of Total ($150 million) (County numbers refer to distribution to the county governments after payment to cities within county borders has been made. Minimum distribution to each county is $1000.) Municipal Area Allocation Municipal Area Allocation Abbott $688 Lakeport $463 Abernathy $110 Lakeside $4,474 Abilene $563,818 Lakeside City $222 Ackerly $21 Lakeview $427 Addison $58,094 Lakeway $31,657 Adrian $181 Lakewood Village $557 Agua Dulce $43 Lamar County $141,598 Alamo $22,121 Lamb County $50,681 Alamo Heights $28,198 Lamesa $29,656 Alba $3,196 Lampasas $28,211 Albany $180 Lampasas County $42,818 Aledo $331 Lancaster $90,653 Alice $71,291 Laredo $763,174 Allen $315,081 Latexo $124 Alma $1,107 Lavaca County $45,973 Alpine $29,686 Lavon $7,435 Alto $3,767 Lawn $58 Alton $11,540 League City $302,418 Alvarado $29,029 Leakey $256 Alvin $113,962 Leander $88,641 Alvord $358 Leary $797 Amarillo $987,661 Lee County $30,457 Ames $5,571 Lefors $159 Amherst $22 Leon County $67,393 Anahuac $542 Leon Valley $23,258 Anderson $19 Leona $883 Anderson County $268,763 Leonard $8,505 Andrews $18,983 Leroy $176 Andrews County $37,606 Levelland $46,848 Angelina County $229,956 Lewisville $382,094 Angleton $62,791 Lexington $2,318 Angus $331 Liberty $72,343 Anna $9,075 Liberty County $531,212 Annetta $5,956 Liberty Hill $2,780 Annetta North $34 Limestone County $135,684 (Table continues on multiple pages below) Annetta South Annona Anson Anthony Anton Appleby Aquilla Aransas County Aransas Pass Archer City Archer County Arcola Argyle Arlington Armstrong County Arp Asherton Aspermont Atascosa County Athens Atlanta Aubrey Aurora Austin County Austin Austwell Avery Avinger Azle Bailey Bailey County Bailey's Prairie Baird Balch Springs Balcones Heights Ballinger Balmorhea Bandera Bandera County Bangs $602 $738 $5,134 $4,514 $444 $1,551 $208 $266,512 $57,813 $10,554 $45,534 $7,290 $11,406 $735,803 $974 $2,009 $112 $9 $176,903 $105,942 $30,995 $15,141 $1,849 $76,030 $4,877,716 $109 $138 $1,115 $32,213 $950 $15,377 $5,604 $2,802 $27,358 $23,811 $9,172 $63 $2,893 $86,815 $3,050 Lincoln Park Lindale Linden Lindsay Lipan Lipscomb County Little Elm Little River -Academy Littlefield Live Oak Live Oak County Liverpool Livingston Llano Llano County Lockhart Lockney Log Cabin Lometa Lone Oak Lone Star Longview Loraine Lorena Lorenzo Los Fresnos Los Indios Los Ybanez Lott Lovelady Loving County Lowry Crossing Lubbock Lubbock County Lucas Lueders Lufkin Luling Lumberton Lyford $677 $24,202 $3,661 $1,228 $44 $10,132 $69,326 $798 $7,678 $32,740 $39,716 $1,435 $73,165 $23,121 $115,647 $49,050 $3,301 $1,960 $1,176 $1,705 $8,283 $482,254 $188 $3,390 $11,358 $11,185 $159 $0 $1,516 $249 $1,000 $783 $319,867 $1,379,719 $5,266 $508 $281,592 $29,421 $36,609 $3,071 Page 2 Bardwell $362 Barry $200 Barstow $61 Bartlett $3,374 Bartonville $8,887 Bastrop $46,320 Bastrop County $343,960 Bay City $57,912 Baylor County $29,832 Bayou Vista $6,240 Bayside $242 Baytown $216,066 Bayview $41 Beach City $12,505 Bear Creek $906 Beasley $130 Beaumont $683,010 Beckville $1,247 Bedford $94,314 Bedias $3,475 Bee Cave $12,863 Bee County $97,844 Beeville $24,027 Bell County $650,748 Bellaire $41,264 Bellevue $56 Bellmead $14,487 Bells $1,891 Bellville $7,488 Belton $72,680 Benavides $152 Benbrook $43,919 Benjamin $951 Berryville $14,379 Bertram $182 Beverly Hills $4,336 Bevil Oaks $549 Bexar County $7,007,152 Big Lake $547 Big Sandy $4,579 Lynn County $6,275 Lytle $7,223 Mabank $19,443 Madison County $49,492 Madisonville $11,458 Magnolia $26,031 Malakoff $12,614 Malone $439 Manor $12,499 Mansfield $150,788 Manvel $12,305 Marble Falls $37,039 Marfa $65 Marietta $338 Marion $275 Marion County $54,728 Marlin $21,634 Marquez $1,322 Marshall $108,371 Mart $928 Martin County $10,862 Martindale $2,437 Mason $777 Mason County $3,134 Matador $1,203 Matagorda County $135,239 Mathis $15,720 Maud $423 Maverick County $115,919 Maypearl $986 McAllen $364,424 McCamey $542 McGregor $9,155 McKinney $450,383 McLean $14 McLendon -Chisholm $411 Mcculloch County $20,021 Mclennan County $529,641 Mcmullen County $1,000 Meadow $1,121 Page 3 Big Spring Big Wells Bishop Bishop Hills Blackwell Blanco Blanco County Blanket Bloomburg Blooming Grove Blossom Blue Mound Blue Ridge Blum Boerne Bogata Bonham Bonney Booker Borden County Borger Bosque County Bovina Bowie Bowie County Boyd Brackettville Brady Brazoria Brazoria County Brazos Bend Brazos Country Brazos County Breckenridge Bremond Brenham Brewster County Briarcliff Briaroaks Bridge City $189,928 $236 $8,213 $323 $31 $6,191 $49,223 $147 $1,010 $352 $198 $2,888 $1,345 $1,622 $45,576 $3,649 $100,909 $2,510 $1,036 $1,000 $69,680 $71,073 $173 $83,620 $233,190 $6,953 $8 $27,480 $11,537 $1,021,090 $462 $902 $342,087 $23,976 $5,554 $54,750 $60,087 $572 $57 $80,756 Meadowlakes Meadows Place Medina County Megargel Melissa Melvin Memphis Menard Menard County Mercedes Meridian Merkel Mertens Mertzon Mesquite Mexia Miami Midland County Midland Midlothian Midway Milam County Milano Mildred Miles Milford Miller's Cove Millican Mills County Millsap Mineola Mineral Wells Mingus Mission Missouri City Mitchell County Mobeetie Mobile City Monahans Mont Belvieu $905 $18,148 $48,355 $611 $15,381 $345 $7,203 $991 $14,717 $21,441 $3,546 $10,117 $239 $29 $310,709 $21,096 $455 $279,927 $521,849 $95,799 $78 $97,386 $904 $286 $93 $6,177 $97 $417 $19,931 $34 $48,719 $92,061 $189 $124,768 $209,633 $20,850 $52 $2,034 $5,849 $19,669 Page 4 Bridgeport $33,301 Briscoe County $977 Broaddus $31 Bronte $99 Brooks County $20,710 Brookshire $6,406 Brookside Village $1,110 Brown County $193,417 Browndell $152 Brownfield $14,452 Brownsboro $3,176 Brownsville $425,057 Brownwood $166,572 Bruceville-Eddy $1,692 Bryan $246,897 Bryson $1,228 Buckholts $1,113 Buda $10,784 Buffalo $11,866 Buffalo Gap $88 Buffalo Springs $188 Bullard $7,487 Bulverde $14,436 Bunker Hill Village $472 Burkburnett $37,844 Burke $1,114 Burleson County $70,244 Burleson $151,779 Burnet $33,345 Burnet County $189,829 Burton $937 Byers $77 Bynum $380 Cactus $4,779 Caddo Mills $43 Caldwell $18,245 Caldwell County $86,413 Calhoun County $127,926 Callahan County $12,894 Callisburg $101 Montague County $94,796 Montgomery $1,884 Montgomery County $2,700,911 Moody $828 Moore County $40,627 Moore Station $772 Moran $50 Morgan $605 Morgan's Point $3,105 Morgan's Point Resort $8,024 Morris County $53,328 Morton $167 Motley County $3,344 Moulton $999 Mount Calm $605 Mount Enterprise $1,832 Mount Pleasant $65,684 Mount Vernon $6,049 Mountain City $1,548 Muenster $4,656 Muleshoe $4,910 Mullin $384 Munday $2,047 Murchison $2,302 Murphy $51,893 Mustang $7 Mustang Ridge $2,462 Nacogdoches $205,992 Nacogdoches County $198,583 Naples $4,224 Nash $7,999 Nassau Bay $11,247 Natalia $625 Navarro $334 Navarro County $103,513 Navasota $37,676 Nazareth $124 Nederland $44,585 Needville $10,341 Nevada $237 Page 5 Calvert $772 Cameron $11,091 Cameron County $537,026 Camp County $28,851 Camp Wood $422 Campbell $1,116 Canadian $1,090 Caney City $2,005 Canton $56,734 Canyon $26,251 Carbon $620 Carl's Corner $48 Carmine $385 Carrizo Springs $1,671 Carrollton $310,255 Carson County $29,493 Carthage $18,927 Cashion Community $322 Cass County $93,155 Castle Hills $12,780 Castro County $4,420 Castroville $4,525 Cedar Hill $70,127 Cedar Park $185,567 Celeste $1,280 Celina $18,283 Center $58,838 Centerville $385 Chambers County $153,188 Chandler $17,364 Channing $2 Charlotte $4,257 Cherokee County $156,612 Chester $1,174 Chico $2,928 Childress $37,916 Childress County $50,582 Chillicothe $172 China $522 China Grove $598 New Berlin $4 New Boston $6,953 New Braunfels $307,313 New Chapel Hill $288 New Deal $338 New Fairview $2,334 New Home $9 New Hope $1,024 New London $4,129 New Summerfield $442 New Waverly $2,562 Newark $520 Newcastle $914 Newton $6,102 Newton County $158,006 Neylandville $163 Niederwald $16 Nixon $2,283 Nocona $16,536 Nolan County $50,262 Nolanville $4,247 Nome $391 Noonday $226 Nordheim $697 Normangee $6,192 North Cleveland $105 North Richland Hills $146,419 Northlake $8,905 Novice $76 Nueces County $1,367,932 O'Brien $76 O'Donnell $27 Oak Grove $2,769 Oak Leaf $612 Oak Point $9,011 Oak Ridge $358 Oak Ridge North $33,512 Oak Valley $7 Oakwood $148 Ochiltree County $15,476 Page 6 Chireno Christine Cibolo Cisco Clarendon Clarksville Clarksville City Claude Clay County Clear Lake Shores Cleburne Cleveland Clifton Clint Clute Clyde Coahoma Cochran County Cockrell Hill Coffee City Coke County Coldspring Coleman Coleman County College Station Colleyville Collin County Collingsworth County Collinsville Colmesneil Colorado City Colorado County Columbus Comal County Comanche Comanche County Combes Combine Commerce Como $1,568 $354 $13,690 $7,218 $114 $20,891 $54 $26 $72,050 $6,682 $228,184 $96,897 $9,939 $375 $51,350 $17,287 $2,291 $3,389 $512 $1,087 $5,522 $447 $5,442 $4,164 $258,147 $46,049 $1,266,721 $19,234 $1,831 $2,211 $8,405 $49,084 $6,867 $396,142 $16,503 $50,964 $1,710 $1,892 $33,869 $415 Odem Odessa Oglesby Old River-Winfree Oldham County Olmos Park Olney Olton Omaha Onalaska Opdyke West Orange Orange County Orange Grove Orchard Ore City Overton Ovilla Oyster Creek Paducah Paint Rock Palacios Palestine Palisades Palm Valley Palmer Palmhurst Palmview Palo Pinto County Pampa Panhandle Panola County Panorama Village Pantego Paradise Paris Parker Parker County Parmer County Pasadena $7,420 $559,163 $29 $21,653 $10,318 $9,801 $6,088 $1,197 $4,185 $31,654 $479 $311,339 $689,818 $1,677 $867 $6,806 $7,900 $13,391 $9,633 $125 $141 $14,036 $178,009 $240 $1,918 $12,666 $4,660 $7,577 $124,621 $67,227 $9,536 $80,699 $1,292 $12,898 $52 $201,180 $10,307 $476,254 $15,866 $356,536 Page 7 Concho County $3,859 Conroe $466,671 Converse $27,693 Cooke County $200,451 Cool $731 Coolidge $243 Cooper $362 Coppell $86,593 Copper Canyon $489 Copperas Cove $133,492 Corinth $75,298 Corpus Christi $1,812,707 Corral City $143 Corrigan $21,318 Corsicana $87,310 Coryell County $123,659 Cottle County $875 Cottonwood $289 Cottonwood Shores $1,203 Cotulla $1,251 Coupland $266 Cove $387 Covington $519 Coyote Flats $1,472 Crandall $12,094 Crane $10,599 Crane County $26,146 Cranfills Gap $128 Crawford $383 Creedmoor $16 Cresson $1,086 Crockett $23,403 Crockett County $18,210 Crosby County $18,388 Crosbyton $1,498 Cross Plains $4,877 Cross Roads $244 Cross Timber $542 Crowell $6,335 Crowley $22,345 Pattison $1,148 Patton Village $9,268 Payne Springs $1,770 Pearland $333,752 Pearsall $11,570 Pecan Gap $719 Pecan Hill $229 Pecos $7,622 Pecos County $46,997 Pelican Bay $1,199 Penelope $415 Penitas $312 Perryton $23,364 Petersburg $1,691 Petrolia $17 Petronila $5 Pflugerville $86,408 Pharr $144,721 Pilot Point $11,613 Pine Forest $3,894 Pine Island $3,141 Pinehurst $32,671 Pineland $4,138 Piney Point Village $15,738 Pittsburg $20,526 Plains $129 Plainview $60,298 Plano $1,151,608 Pleak $270 Pleasant Valley $308 Pleasanton $29,011 Plum Grove $258 Point $1,519 Point Blank $355 Point Comfort $447 Point Venture $588 Polk County $370,831 Ponder $1,282 Port Aransas $31,022 Port Arthur $367,945 Page 8 Crystal City Cuero Culberson County Cumby Cuney Cushing Cut and Shoot DISH Daingerfield Daisetta Dalhart Dallam County Dallas County Dallas Dalworthington Gardens Danbury Darrouzett Dawson Dawson County Dayton Dayton Lakes De Kalb De Leon De Witt County DeCordova DeSoto Deaf Smith County Dean Decatur Deer Park Del Rio Dell City Delta County Denison Denton Denton County Denver City Deport Detroit Devers $19,412 $24,689 $789 $5,320 $606 $1,120 $2,141 $19 $12,476 $5,370 $11,609 $21,686 $8,538,291 $2,999,902 $6,060 $4,231 $101 $600 $46,911 $47,122 $38 $1,035 $8,218 $68,895 $13,778 $72,400 $34,532 $141 $56,669 $49,388 $59,056 $15 $30,584 $210,426 $458,334 $1,132,298 $2,104 $42 $965 $191 Port Isabel Port Lavaca Port Neches Portland Post Post Oak Bend City Poteet Poth Potter County Pottsboro Powell Poynor Prairie View Premont Presidio Presidio County Primera Princeton Progreso Progreso Lakes Prosper Providence Village Putnam Pyote Quanah Queen City Quinlan Quintana Quitaque Quitman Rains County Ralls Rancho Viejo Randall County Ranger Rankin Ransom Canyon Ravenna Raymondville Reagan County $9,802 $11,752 $38,849 $76,517 $2,332 $1,034 $6,767 $3,974 $371,701 $12,302 $110 $1,180 $7,600 $3,321 $148 $787 $2,958 $19,245 $8,072 $39 $22,770 $508 $14 $22 $207 $4,837 $7,304 $492 $8 $15,619 $53,190 $3,967 $3,836 $278,126 $12,186 $1,613 $930 $685 $7,466 $25,215 Page 9 Devine Diboll Dickens Dickens County Dickinson Dilley Dimmit County Dimmitt Dodd City Dodson Domino Donley County Donna Dorchester Double Oak Douglassville Dripping Springs Driscoll Dublin Dumas Duncanville Duval County Eagle Lake Eagle Pass Early Earth East Bernard East Mountain East Tawakoni Eastland Eastland County Easton Ector Ector County Edcouch Eden Edgecliff Village Edgewood Edinburg Edmonson $4,354 $25,533 $71 $1,873 $83,683 $2,633 $33,294 $1,012 $1,211 $447 $196 $22,370 $13,798 $231 $4,765 $574 $811 $39 $14,478 $26,229 $58,328 $49,109 $4,882 $56,005 $14,838 $242 $5,554 $2,494 $2,723 $15,896 $52,275 $329 $1,108 $480,000 $4,101 $497 $2,232 $13,154 $120,884 $136 Real County Red Lick Red Oak Red River County Redwater Reeves County Refugio Refugio County Reklaw Reno Reno Retreat Rhome Rice Richardson Richland Richland Hills Richland Springs Richmond Richwood Riesel Rio Bravo Rio Grande City Rio Hondo Rio Vista Rising Star River Oaks Riverside Roanoke Roaring Springs Robert Lee Roberts County Robertson County Robinson Robstown Roby Rochester Rockdale Rockport Rocksprings $5,073 $23 $26,843 $29,306 $1,058 $103,350 $8,839 $46,216 $1,136 $3,791 $11,164 $52 $12,285 $1,972 $260,315 $210 $24,438 $2,234 $77,606 $12,112 $1,118 $8,548 $25,947 $3,550 $4,419 $1,933 $11,917 $858 $275 $461 $85 $547 $44,642 $18,002 $40,154 $428 $674 $20,973 $54,253 $25 Page 10 Edna $18,194 Edom $2,149 Edwards County $975 El Campo $31,700 El Cenizo $621 El Lago $5,604 El Paso $1,224,371 El Paso County $2,592,121 Eldorado $50 Electra $15,716 Elgin $26,284 Elkhart $301 Ellis County $315,372 Elmendorf $746 Elsa $7,720 Emhouse $83 Emory $3,878 Enchanted Oaks $1,299 Encinal $1,515 Ennis $81,839 Erath County $102,616 Escobares $40 Estelline $909 Euless $92,824 Eureka $334 Eustace $2,089 Evant $2,068 Everman $7,692 Fair Oaks Ranch $8,077 Fairchilds $81 Fairfield $1,245 Fairview $32,245 Falfurrias $2,221 Falls City $41 Falls County $34,522 Fannin County $131,653 Farmers Branch $94,532 Farmersville $10,532 Farwell $343 Fate $3,473 Rockwall $114,308 Rockwall County $168,820 Rocky Mound $280 Rogers $3,818 Rollingwood $4,754 Roma $16,629 Roman Forest $8,610 Ropesville $2,122 Roscoe $778 Rose City $4,012 Rose Hill Acres $2,311 Rosebud $1,489 Rosenberg $126,593 Ross $147 Rosser $549 Rotan $1,493 Round Mountain $454 Round Rock $475,992 Round Top $140 Rowlett $99,963 Roxton $47 Royse City $23,494 Rule $800 Runaway Bay $6,931 Runge $255 Runnels County $33,831 Rusk $17,991 Rusk County $151,390 Sabinal $1,811 Sabine County $46,479 Sachse $23,400 Sadler $925 Saginaw $31,973 Salado $3,210 San Angelo $536,509 San Antonio $4,365,416 San Augustine $25,182 San Augustine County $37,854 San Benito $40,015 San Diego $11,771 Page 11 Fayette County $92,440 Fayetteville $391 Ferris $13,873 Fisher County $5,518 Flatonia $5,661 Florence $3,949 Floresville $21,699 Flower Mound $215,256 Floyd County $9,049 Floydada $6,357 Foard County $5,764 Follett $212 Forest Hill $26,132 Forney $80,112 Forsan $576 Fort Bend County $1,506,719 Fort Stockton $4,411 Fort Worth $2,120,790 Franklin $3,931 Franklin County $25,783 Frankston $274 Fredericksburg $56,486 Freeport $72,973 Freer $3,271 Freestone County $50,495 Friendswood $140,330 Frio County $19,954 Friona $2,848 Frisco $405,309 Fritch $4,548 Frost $321 Fruitvale $2,344 Fulshear $5,272 Fulton $1,602 Gaines County $54,347 Gainesville $153,980 Galena Park $13,093 Gallatin $1,253 Galveston $488,187 Galveston County $1,124,093 San Elizario San Felipe San Jacinto County San Juan San Leanna San Marcos San Patricio San Patricio County San Perlita San Saba San Saba County Sanctuary Sandy Oaks Sandy Point Sanford Sanger Sansom Park Santa Anna Santa Clara Santa Fe Santa Rosa Savoy Schertz Schleicher County Schulenburg Scotland Scottsville Scurry Scurry County Seabrook Seadrift Seagoville Seagraves Sealy Seguin Selma Seminole Seven Oaks Seven Points Seymour $7,831 $1,498 $197,398 $28,845 $36 $325,688 $4,213 $271,916 $2,219 $10,057 $17,562 $17 $9,863 $1,637 $308 $22,237 $223 $329 $87 $33,272 $2,138 $2,349 $60,110 $5,695 $2,560 $148 $708 $1,110 $73,116 $30,270 $991 $17,106 $7,531 $20,637 $376,538 $22,429 $16,092 $3,917 $7,452 $14,218 Page 12 Ganado $5,510 Garden Ridge $11,351 Garland $420,244 Garrett $2,510 Garrison $3,555 Gary City $450 Garza County $8,944 Gatesville $26,994 George West $6,207 Georgetown $225,896 Gholson $1,505 Giddings $12,674 Gillespie County $63,191 Gilmer $33,951 Gladewater $24,638 Glasscock County $1,000 Glen Rose $540 Glenn Heights $16,593 Godley $3,115 Goldsmith $677 Goldthwaite $1,225 Goliad $3,563 Goliad County $34,660 Golinda $100 Gonzales $14,882 Gonzales County $33,230 Goodlow $221 Goodrich $9,643 Gordon $365 Goree $749 Gorman $3,107 Graford $23 Graham $235,428 Granbury $71,735 Grand Prairie $445,439 Grand Saline $36,413 Grandfalls $65 Grandview $6,600 Granger $2,741 Granite Shoals $11,834 Shackelford County $1,288 Shady Shores $594 Shallowater $1,907 Shamrock $4,328 Shavano Park $3,178 Shelby County $109,925 Shenandoah $47,122 Shepherd $147 Sherman $330,585 Sherman County $7,930 Shiner $4,042 Shoreacres $958 Silsbee $66,442 Silverton $14 Simonton $1,906 Sinton $23,658 Skellytown $400 Slaton $154 Smiley $655 Smith County $758,961 Smithville $17,009 Smyer $300 Snook $1,422 Snyder $9,018 Socorro $11,125 Somerset $1,527 Somervell County $57,076 Somerville $3,806 Sonora $7,337 Sour Lake $17,856 South Houston $25,620 South Mountain $154 South Padre Island $30,629 Southlake $70,846 Southmayd $7,096 Southside Place $885 Spearman $14,000 Splendora $7,756 Spofford $7 Spring Valley Village $16,404 Page 13 Granjeno $43 Grapeland $7,287 Grapevine $129,195 Gray County $65,884 Grays Prairie $17 Grayson County $539,083 Greenville $203,112 Gregg County $243,744 Gregory $4,697 Grey Forest $474 Grimes County $94,878 Groesbeck $5,745 Groom $965 Groves $40,752 Groveton $8,827 Gruver $1,166 Guadalupe County $146,824 Gun Barrel City $36,302 Gunter $4,609 Gustine $34 Hackberry $94 Hale Center $6,042 Hale County $79,150 Hall County $8,933 Hallettsville $6,895 Hallsburg $272 Hallsville $10,239 Haltom City $71,800 Hamilton $3,581 Hamilton County $66,357 Hamlin $4,656 Hansford County $16,416 Happy $327 Hardeman County $15,219 Hardin $100 Hardin County $379,800 Harker Heights $113,681 Harlingen $165,429 Harris County $14,966,202 Harrison County $185,910 Springlake Springtown Spur St. Hedwig St. Jo St. Paul Stafford Stagecoach Stamford Stanton Staples Star Harbor Starr County Stephens County Stephenville Sterling City Sterling County Stinnett Stockdale Stonewall County Stratford Strawn Streetman Sudan Sugar Land Sullivan City Sulphur Springs Sun Valley Sundown Sunnyvale Sunray Sunrise Beach Village Sunset Valley Surfside Beach Sutton County Sweeny Sweetwater Swisher County Taft Tahoka $3 $14,244 $427 $111 $7,360 $21 $75,145 $3,036 $398 $3,838 $19 $151 $99,896 $35,244 $83,472 $62 $939 $4,097 $741 $1,822 $8,378 $987 $5 $32 $321,561 $6,121 $124,603 $4 $2,592 $3,248 $2,571 $2,083 $9,425 $6,530 $6,541 $4,503 $68,248 $7,251 $5,861 $430 Page 14 Hart $86 Hartley County $786 Haskell $10,829 Haskell County $22,011 Haslet $1,908 Hawk Cove $674 Hawkins $7,932 Hawley $931 Hays $506 Hays County $529,489 Hearne $16,824 Heath $28,751 Hebron $687 Hedley $70 Hedwig Village $13,067 Helotes $15,790 Hemphill $8,035 Hemphill County $14,394 Hempstead $21,240 Henderson $59,966 Henderson County $327,965 Henrietta $2,720 Hereford $20,423 Hewitt $19,776 Hickory Creek $16,510 Hico $5,534 Hidalgo $26,621 Hidalgo County $1,253,103 Hideaway $922 Higgins $43 Highland Haven $320 Highland Park $43,383 Highland Village $50,315 Hill Country Village $6,485 Hill County $127,477 Hillcrest $5,345 Hillsboro $46,609 Hilshire Village $859 Hitchcock $28,796 Hockley County $46,407 Talco Talty Tarrant County Tatum Taylor Taylor County Taylor Lake Village Taylor Landing Teague Tehuacana Temple Tenaha Terrell Terrell County Terrell Hills Terry County Texarkana Texas City Texhoma Texline The Colony The Hills Thompsons Thorndale Thornton Thorntonville Thrall Three Rivers Throckmorton Throckmorton County Tiki Island Timbercreek Canyon Timpson Tioga Tira Titus County Toco Todd Mission Tolar Tom Bean $372 $9,124 $6,171,159 $972 $57,945 $351,078 $412 $153 $1,714 $12 $280,747 $4,718 $148,706 $5,737 $9,858 $25,423 $192,094 $298,702 $156 $865 $114,297 $1,004 $1,897 $1,595 $270 $87 $825 $4,669 $29 $5,695 $2,178 $369 $12,642 $2,390 $185 $70,611 $4 $1,680 $2,369 $2,293 Page 15 Holiday Lakes Holland Holliday Hollywood Park Hondo Honey Grove Hood County Hooks Hopkins County Horizon City Horseshoe Bay Houston County Houston Howard County Howardwick Howe Hubbard Hudson Hudson Oaks Hudspeth County Hughes Springs Humble Hunt County Hunters Creek Village Huntington Huntsville Hurst Hutchins Hutchinson County Hutto Huxley Idalou Impact Indian Lake Industry Ingleside on the Bay Ingleside Ingram Iola Iowa Colony $1,795 $77 $5,910 $9,424 $115,288 $7,196 $292,105 $2,702 $149,518 $7,520 $48,173 $78,648 $7,021,793 $89,330 $84 $9,177 $3,635 $6,840 $15,637 $985 $4,442 $73,952 $309,851 $14,708 $8,792 $80,373 $99,187 $9,551 $74,630 $38,346 $738 $1,999 $8 $473 $604 $142 $40,487 $5,243 $3,164 $4,090 Tom Green County Tomball Tool Toyah Travis County Trent Trenton Trinidad Trinity Trinity County Trophy Club Troup Troy Tulia Turkey Tuscola Tye Tyler Tyler County Uhland Uncertain Union Grove Union Valley Universal City University Park Upshur County Upton County Uvalde Uvalde County Val Verde County Valentine Valley Mills Valley View Van Van Alstyne Van Horn Van Zandt County Vega Venus Vernon $282,427 $34,620 $14,787 $40 $4,703,473 $63 $3,089 $5,859 $23,652 $105,766 $29,370 $7,918 $5,320 $8,911 $737 $138 $1,766 $723,829 $131,743 $1,545 $185 $994 $666 $28,428 $50,833 $128,300 $8,499 $18,439 $36,244 $117,815 $207 $2,228 $1,824 $6,206 $43,749 $211 $248,747 $974 $9,792 $81,337 Page 16 Iowa Park $23,487 Iraan $56 Iredell $216 Irion County $9,105 Irving $427,818 Italy $5,349 Itasca $8,694 Ivanhoe $26 Jacinto City $14,141 Jack County $14,799 Jacksboro $23,254 Jackson County $37,984 Jacksonville $80,179 Jamaica Beach $4,913 Jarrell $2,423 Jasper $78,422 Jasper County $248,855 Jayton $63 Jeff Davis County $8,500 Jefferson $11,194 Jefferson County $756,614 Jersey Village $36,347 Jewett $9,338 Jim Hogg County $12,718 Jim Wells County $166,539 Joaquin $810 Johnson City $3,581 Johnson County $408,692 Jolly $26 Jones County $22,001 Jones Creek $5,078 Jonestown $6,419 Josephine $881 Joshua $20,619 Jourdanton $9,600 Junction $4,825 Justin $8,575 Karnes City $11,632 Karnes County $35,249 Katy $52,467 Victoria $84,598 Victoria County $520,886 Vidor $95,620 Vinton $622 Volente $333 Von Ormy $513 Waco $512,007 Waelder $3,427 Wake Village $174 Walker County $184,624 Waller County $126,206 Waller $11,295 Wallis $2,698 Walnut Springs $183 Ward County $67,920 Warren City $66 Washington County $83,727 Waskom $5,346 Watauga $33,216 Waxahachie $152,094 Weatherford $207,872 Webb County $505,304 Webberville $1,280 Webster $53,202 Weimar $5,830 Weinert $234 Weir $443 Wellington $9,111 Wellman $383 Wells $1,357 Weslaco $73,949 West $3,522 West Columbia $17,958 West Lake Hills $17,056 West Orange $42,452 West Tawakoni $6,995 West University Place $34,672 Westbrook $43 Westlake $41,540 Weston $266 Page 1? Kaufman $27,607 Kaufman County $353,047 Keene $38,296 Keller $79,189 Kemah $28,325 Kemp $6,419 Kempner $330 Kendall County $100,643 Kendleton $13 Kenedy $676 Kenedy County $1,000 Kenefick $416 Kennard $132 Kennedale $21,024 Kent County $939 Kerens $1,924 Kermit $5,652 Kerr County $218,452 Kerrville $190,357 Kilgore $105,583 Killeen $535,650 Kimble County $20,480 King County $1,000 Kingsville $20,083 Kinney County $2,142 Kirby $8,752 Kirbyville $10,690 Kirvin $2 Kleberg County $124,109 Knollwood $1,160 Knox City $1,962 Knox County $11,730 Kosse $2,468 Kountze $19,716 Kress $186 Krugerville $1,508 Krum $9,661 Kurten $686 Kyle $51,835 La Feria $10,381 Weston Lakes Westover Hills Westworth Village Wharton Wharton County Wheeler Wheeler County White Deer White Oak White Settlement Whiteface Whitehouse Whitesboro Whitewright Whitney Wichita County Wichita Falls Wickett Wilbarger County Willacy County Williamson County Willis Willow Park Wills Point Wilmer Wilson Wilson County Wimberley Windcrest Windom Windthorst Winfield Wink Winkler County Winnsboro Winona Winters Wise County Wixon Valley Wolfe City $189 $4,509 $7,842 $31,700 $72,887 $447 $26,273 $1,273 $15,305 $23,304 $155 $29,017 $18,932 $7,098 $73 $552,371 $832,574 $87 $55,124 $24,581 $1,195,987 $24,384 $26,737 $43,765 $426 $12 $121,034 $724 $12,908 $1,087 $3,385 $290 $120 $61,163 $28,791 $319 $6,229 $289,074 $441 $5,466 Page 18 La Grange $9,623 La Grulla $1,708 La Joya $8,457 La Marque $98,930 La Porte $91,532 La Salle County $14,975 La Vernia $3,217 La Villa $572 La Ward $321 LaCoste $159 Lacy -Lakeview $11,599 Ladonia $2,011 Lago Vista $13,768 Laguna Vista $3,689 Lake Bridgeport $232 Lake City $2,918 Lake Dallas $25,314 Lake Jackson $75,781 Lake Tanglewood $613 Lake Worth $20,051 Wolfforth $4,022 Wood County $267,048 Woodbranch $9,617 Woodcreek $358 Woodloch $1,012 Woodsboro $1,130 Woodson $122 Woodville $20,340 Woodway $25,713 Wortham $376 Wylie $114,708 Yantis $2,072 Yoakum County $34,924 Yoakum $20,210 Yorktown $5,447 Young County $44,120 Zapata County $56,480 Zavala County $38,147 Zavalla $1,088 Page 19 EXHIBIT C Exhibit C: TX Opioid Council & Health Care Region Allocations plus Administrative Costs 70% of Total ($700 million) Health Care Region Allocation*: $693 million; Administrative Costs: $7 million Region Counties in Health Care Region Allocation Anderson, Bowie, Camp, Cass, Cherokee, Delta, Fannin, Franklin, Freestone, Gregg, 1 Harrison, Henderson, Hopkins, Houston, Hunt, Lamar, Marion, Morris, Panola, Rains, Red, River, Rusk, Smith, Titus, Trinity, Upshur, Van, Zandt, Wood $38,223,336 2 Angelina, Brazoria, Galveston, Hardin, Jasper, Jefferson, Liberty, Nacogdoches, Newton, Orange, Polk, Sabine, San Augustine, San Jacinto, Shelby, Tyler $54,149,215 3 Austin, Calhoun, Chambers, Colorado, Fort Bend, Harris, Matagorda, Waller, Wharton Aransas, Bee, Brooks, De Witt, Duval, Goliad, Gonzales, Jackson, Jim Wells, Karnes, Kenedy, Kleberg, Lavaca, Live Oak, Nueces, Refugio, San Patricio, Victoria 4 $120,965,680 $27,047,477 5 Cameron, Hidalgo, Starr, Willacy Atascosa, Bandera, Bexar, Comal, Dimmit, Edwards, Frio, Gillespie, Guadalupe, Kendall, Kerr, Kinney, La Salle, McMullen, Medina, Real, Uvalde, Val Verde, Wilson, Zavala 6 $17,619,875 $68,228,047 7 8 9 10 11 Bastrop, Caldwell, Fayette, Hays, Lee, Travis Bell, Blanco, Burnet, Lampasas, Llano, Milam, Mills, San Saba, Williamson Dallas, Kaufman Ellis, Erath, Hood, Johnson, Navarro, Parker, Somervell, Tarrant, Wise Brown, Callahan, Comanche, Eastland, Fisher, Haskell, Jones, Knox, Mitchell, Nolan, Palo Pinto, Shackelford, Stephens, Stonewall, Taylor $50,489,691 $24,220,521 $66,492,094 $65,538,414 $9,509,818 Armstrong, Bailey, Borden, Briscoe, Carson, Castro, Childress, Cochran, Collingsworth, Cottle, Crosby, Dallam, Dawson, Deaf Smith, Dickens, Donley, Floyd, Gaines, Garza, 12 Gray, Hale, Hall, Hansford, Hartley, Hemphill, Hockley, Hutchinson, Kent, King, Lamb, Lipscomb, Lubbock, Lynn, Moore, Motley, Ochiltree, Oldham, Parmer, Potter, Randall, Roberts, Scurry, Sherman, Swisher, Terry, Wheeler, Yoakum $23,498,027 13 Coke, Coleman, Concho, Crockett, Irion, Kimble, Mason, McCulloch, Menard, Pecos, Reagan, Runnels, Schleicher, Sterling, Sutton, Terrell, Tom Green $5,195,605 14 Andrews, Brewster, Crane, Culberson, Ector, Glasscock, Howard, Jeff Davis, Loving, Martin, Midland, Presidio, Reeves, Upton, Ward, Winkler $12,124,354 15 El Paso, Hudspeth 16 Bosque, Coryell, Falls, Hamilton, Hill, Limestone, McLennan 17 Brazos, Burleson, Grimes, Leon, Madison, Montgomery, Robertson, Walker, Washington 18 Collin, Denton, Grayson, Rockwall Archer, Baylor, Clay, Cooke, Foard, Hardeman, Jack, Montague, Throckmorton, Wichita, Wilbarger, Young 19 $17,994,285 $9,452,018 $23,042,947 $39,787,684 $12,665,268 20 Jim Hogg, Maverick, Webb, Zapata Administrative Costs $6,755,656 $7,000,000 * Each Region shall reserve 25% of its allocation for Targeted Funds under the guidelines of Exhibit A. UNT Health Fort Worth, EXHIBIT "B" College of Public Health PROGRAM SUMMARY PROGRAM SUMMARY (Texas Opioid Abatement Fund Council TOAFC) October 1, 2025 to September 30, 2026 PERIOD $227,156.00 AMOUNT Capitalized terms not defined herein shall have meanings assigned them in the Contract. PROGRAM: This program would be an extension of current relationships and interventions from our previous COFW funding with key partners within Fort Worth, changing the focus to abate maternal and youth mortality from opioid overdose. In our previous grant execution, we met and exceeded the original targets. The method by which the training will be distributed will be threefold: First, the intervention will provide educational training for trainers within 10 Fort Worth -based organizations and groups through our partnership with the Health Equity Alliance, serving perinatal, pregnant, and postpartum mothers. These sessions will focus on families and involve students from various health profession programs at HSC, along with staff and volunteers from these local community -based organizations. These 250 trained trainers will be empowered to provide ongoing Naloxone education for other groups and their own planned outreach for sustainability. Second, we will partner with Challenge of Tarrant County to conduct outreach efforts in community settings and schools to empower parents using both an educational presentation and virtual reality (VR) training produced from our previous COFW grant, designed to equip them with the skills to have difficult conversations with their children to prevent opioid use. This outreach will be conducted with 300 parents as a pilot of the VR training to provide data to support COTC's HHS program that will provide sustainability to our efforts. The pilot will take place over the summer, leveraging COTC's and HSC's community partner relationships to access parents. In addition, the pilot will serve to evaluate and provide CQI to the training developed from the previous COFW opioid abatement grant. Lastly, we will partner with MedStar Mobile Health and FWFD's "nurturing futures" program and first responders to provide training to at least 50 paramedics in motivational interviewing techniques around opioid use to deploy in interactions with opioid-using perinatal women to help abate substance use and prevent maternal mortality. By embedding these skills among first responders, we will create ongoing maternal opioid abatement on the front lines, intervening at a point to prevent these tragic deaths. All trained trainers will provide outreach, executing training within the community, schools, and home settings to magnify and promote the sustainability of the HSC efforts targeted towards mothers and families. INTERVENTIONS OF OPIOID USE 2025-2026 — EXHIBIT `B" — PROGRAM SUMMARY Page 1 PROGRAM GOALS: Minimum Number of Fort Worth Clients to be Served: The Program must serve a minimum of 10 Fort Worth -based Maternal Health Organizations (25 per training), 300 parents, and 50 paramedics. This will yield 600 Unduplicated Clients for the primary trainings, with exponentially more expected by the trained trainers (which we will also track) from Fort Worth as shown by the monthly reports on Attachment III. INTERVENTIONS OF OPIOID USE 2025-2026 — EXHIBIT "B" — PROGRAM SUMMARY Page 2 EXHIBIT "C" - BUDGET Grant Budget Total PROGRAM PERSONNEL Salaries $87,824.00 $87,824.00 Fringe $19,340.00 $19,340.00 SUPPLIES AND SERVICES Small Deterra Drug Deactivation Pouches $4,600.00 $4,600.00 Organization Training Associated Fees $15,000.00 $15,000.00 Parent Training Incentive $15,000.00 $15,000.00 VR Training Quality Improvement $5,000.00 $5,000.00 MedStar/FWFD Training Incentive $15,000.00 $15,000.00 Conference Travel $4,500.00 $4,500.00 Local Mileage $2,000.00 $2,000.00 Facility and Utilities F&A rate (35% based on direct cost of $168,264) $58,892.00 $58,892.00 BUDGET TOTAL $227,156.00 Page 1 The following tables were created for the purpose of preparing, negotiating, and determining the cost reasonableness and cost allocation method used by the Agency for the line item budget represented on the first page of this EXHIBIT "C" — Budget. The information reflected in the tables is to be considered part of the terms and conditions of the Contract. Agency must have prior written approval by the City to make changes to any line item in the Budget as outlined in Section 5.2.2 in the Contract. The deadline to make changes to EXHIBIT "C" — Budget is April 30th, 2026. SALARY DETAIL -PROGRAM PERSONNEL Position Title Annual Salary Est. Percent to Grant Amount to Grant Teresa Wagner - PD/PI $ 147,000.00 25.0% $ 36,750 Emily Spences - Co -I $ 189,060.00 5.0% $ 9,453 Scott Walters - MI Lead $ 234,216.00 5.0% $ 11,711 Elizabeth Wells-Beede - VR Team $ 263,424.00 2.5% $ 6,586 Rebecca Burns - VR Team $ 199,092.00 5.0% $ 9,955 Richard Cody Bruce - VR Team $ 147,384.00 5.0% $ 7,369 TBD - Grad Research Assistant $ 6,000.00 100.0% $ 6,000 TOTAL $ 1,186,176.00 $ 87,824.00 FRINGE DETAIL -PROGRAM PERSONNEL Percent of Payroll Amount Est. Percent to Grant Amount to Grant The HSC fringe benefit rate is 23% for faculty, 33% for staff and 8.65% for student and part-time employees. Pooled average fringe benefit rates are used at the proposal stage. Actuals rates are charged at the time of award. Retirement Contribution 8.25% $ 7,245.00 100.0% $ 7,245.00 FICA - UNT employer portion on wages to $168,600 for CY2024, $176,100 for CY20254 7.65% $ 6,719.00 100.0% $ 6,719.00 Benefit Replacement Pay (BRP) 5.122% $ 4,498.00 100.0% $ 4,498.00 Texas Unemployment Compensation & Worker's Compensation 1.00% $ 878.00 100.0% $ 878.00 TOTAL $ 19,340.00 $ 19,340.00 SUPPLIES AND SERVICES Total Budget Est. Percent to Grant Amount to Grant Small Deterra Drug Deactivation Pouches $ 4,600.00 100.0% $ 4,600.00 600 Naloxone Units - Donated by Comm $ - 0.0% $ - Partner TOTAL $ 4,600.00 $ 4,600.00 MISCELLANEOUS Total Budget Est. Percent to Grant Amount to Grant Organization Training Associated Fees $ 15,000.00 100.0% $ 15,000.00 Parent Training Incentive $ 15,000.00 100.0% $ 15,000.00 VR Training Quality Improvement $ 5,000.00 100.0% $ 5,000.00 MedStar/FWFD Training Incentive $ 15,000.00 100.0% $ 15,000.00 Conference Travel $ 4,500.00 100.0% $ 4,500.00 Local Mileage $ 2,000.00 100.0% $ 2,000 TOTAL $ 56,500.00 $ 56,500 FACILITY AND UTILITIES Total Budget Est. Percent to Grant Amount to Grant F&A rate (35% based on direct cost of $168,264) $ 58,892.00 100.0% $ 58,892 TOTAL $ 58,892.00 $ 58,892 LEGAL, FINANCIAL AND INSURANCE Total Budget Est. Percent to Grant Amount to Grant Fidelity Bond or Equivalent Directors and Officers General Commercial Liability Prof Fees TOTAL $ - DIRECT ASSISTANCE Total Budget Est. Percent to Grant Amount to Grant Audit/IT/Legal Volunteer Recruitment, Misc. TOTAL $ - EXHIBIT "D" Reimbursement Forms (UNT Health Forms for Reimbursement Request) EXHIBIT "D" Reimbursement Forms (UNT Health Forms for Reimbursement Request) Project RF40080 Function 200 Sum of Amount Year Period 2023 Account Description 5 6 7 50141 Salaries -Professional Admin 50143 Salaries -Staff 50401 Longevity Pay 50501 Payroll Tax Expense 50505 Retirement Expense-ORP 50507 Retirement Expense-TRS 50511 Employee Group Insurance 50519 TRS New Members 50525 Other Payroll Related Costs 51633 Food Svc-Catering-Exp 52505 TIS Mileage 52509 TIS Incidental Exp 52531 TOS Non -Airfare -Public Trans 52533 TOS Airfare 52535 TOS Mileage 52537 TOS Meals -Overnight Travel 52539 TOS Lodging-Ovrnt Travel 52541 TOS Incidental Exp 53001 Supplies -Office 53103 Computer Equipment-NonCap 53104 Computer Equipment -Controlled 55261 Conference Registration 55351 Business Meals 55405 Testing, Grading, Exam Svcs 55999 General Other Expense 56000 F&A Expense Grand Total 8 2025 9 10 11 12 1 2 3 4 Grand Total 5 Unit Year Period Date Journal ID Account Description Amount Line Descr Fund Cai Fund Descr Function Dept Project Ref Line # Fund Cat Descr Function Desc Prograr Program Fund Fund Desc Site Site Desc Purpose Purpose PC Bus Unit Proj Activity An Typ( Sourc( Descr Account Project Employee Name Job Title Actuals Total Fringe Total Salary & Fringe Payroll End Date Check Date Journal ID Paycheck Number Journal Date E c a) O L 30 as a aa)) c w W 3 0 a) a a) E E o o O c U u a •o w () C. O t U o ca Q W U 0_ CA a) r c m 3 a) L o CO N a) C a) E o 6 0 a> ' N N cc. r 0 >' f y U N C.)O E 4.. o 0 RS c m IS U Y 0 a) y... o. rn 0 - 2 3 0 0 ai c N > a@i 0 i m E 0 co 0 co c o L_ Y.its1 a) Q c o N O a CD U o .c t t o c O _ a) o La W °) Z a) a)'' L a) d G •16 ij fa) o o_ m❑ O H c W fq H N O >+ as t 0 W 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O O EA ca 0 0 0 0 Sponsored Total: Non Sponsored 0 0 Non Sponsored Total: Grand Total: am in a position that provides me with suitable means of verification that the work was performed. w 0 SIGNATURE: PRINT NAME: Reimbursement Request Form Subrecipient: Unique Entity Identifier: Reporting Period: SAM.gov expiration: Preparers Email: Preparer's Phone: EXPENSE CATEGORY Approved Budget Reimbursement Request YTD Expense Budget Balance PERSONNEL Salaries $ $ $ $ Subtotal $ $ $ $ FRINGE Payroll Taxes $ $ $ $ Health Insurance/Retirement $ $ $ Subtotal $ $ $ $ TRAVEL Airfare, Hotel, Mileage Reimbursement $ $ $ Subtotal $ $ - $ $ EQUIPMENT $ $ - $ $ - $ Subtotal $ - $ - $ - $ SUPPLIES $ - $ $ $ $ $ - $ $ - Subtotal $ $ - $ $ CONTRACTUAL $ - $ - $ $ $ $ $ $ - $ Subtotal $ $ $ $ OTHER $ $ $ $ $ - $ $ - Subtotal $ $ - $ $ Total Direct $ $ $ $ Indirect 10% MDTC $ $ $ $ Subtotal $ $ $ $ TOTAL $ Total Request for Reimbursement: $ I certify to the best of my knowledge that the information provided herein is true and complete and that reimbursement for these expenses has not been request from any other source. Signature Title: Date Summary - Supplier Invoice No. (Doc. No. ) Invoice Summary - Supplier Invoice No. (Doc. No. ) Supplier Invoice No. Supplier Name General Invoice Information Business Unit Invoice Type Invoice Number Supplier Invoice No. Supplier No. Supplier Name y Status Dates Information Create Date Invoice Receipt Date (mm/dd/yyyy) Invoice Date Due Date Invoice Received Date Service Receipt Date (mm/dd/yyyy) Accounting Date Discount Date General Information Is Supplier a Foreign Vendor? Terms Invoiced By Invoke Source Match Status no value Purchase Order Information Invoice Owner Procurement Method RFP Invoice Name Invoiced by user department Buyer_ID Delivery Location Previous PO Is this a exclusive acquisition request? Contains substituted item(s), Terms Discount Addresses Remit To Remit To Location edit List Bill To Payment Information Returned Payment Information Payment Method Payment Record No. Payment Record Date Note/Attachments External Note Internal Note & Approval Justification External Attachments Internal Attachments Discount, Tax, Shipping & Handling Discount, tax, shipping & handling Allocation Sum of All Header -level Sum of lines Terms Discount0.00 USD Discount 0.00 USD 0.00 USD Tax 1 0.00 USD 0.00 USD Tax 2 0.00 USD 0.00 USD Shipping 0.00 USD 0.00 USD Handling 0.00 USD 0.00 USD Total USD Codes Accounting Codes Values vary by line. LINE 1/2 Business_Unit Speedchart Account Department Fund Fund Function Project PC Activity Program Purpose Site Category Business Unit no value no value no value no value no value no value no value no value no value no value no value no value no value Accounting Codes Values vary by line. Line Item Details - Product Description Line 1 1 Service Total Amount Accounting Codes values Catalog No Size / Packaging Unit Price Quantity Ext. Price Business_Unit Speedchart Account Department Fund Fund Function Project PC Activity Program Purpose Site Category Business Unit Svcs Service Start Date Service End Date no value no no Other Sponsored Research- Health Project_activity value value Federal Restricted- Sponsored Science Flow Projects Center Throughs PO Number PO Department Substitute Item Taxable Capital Expense Line Match Status Matching Summary Ordered Quantity: Ext. Price: USD Received Net Invoiced USD Related Documents Invoices: 13 / Credits: 0 / Receipts: 0 show list Contract No. Business Unit External Note no note Internal Note no note External Line Attachments Internal Line Attachments Discount_tu_shipaig & handling Line -level Discount 0.00 USD Tax 1 0.00 USD Tax 2 0.00 USD Shipping 0.00 USD Handling 0.00 USD Subtotal Discount 0.00 Taxi 0.00 Tax2 0.00 Shipping 0.00 Handling 0.00 Total USD Executive Summary I. Dates, Details, and Locations of Trainings Held A. Number of Organizations Trained B. Attendance Numbers 1. Race/Ethnicity 2. Gender C. Outline of Types of Organizations D. Number of Narcan and Drug Disposal Bags Distributed II. Types of Employees Trained and their Zip Code A. Number that the Organization Serves and Zip Codes typically Served. B. Populations Typically Served III. Subsequent Trainings Held A. Number of Organizations Trained B. Outline of Types of Organizations IV. Learner Outcomes as Measured by Pre- and Post-tests 3/27/24.4:25 PM Qualifies Survey Software Demographics Thank you for considering the UNTHSC School of Public Health/SaferCare Texas Narcan Training! Please complete this short survey to request training or to register for training. Your survey results will allow us to determine how many people participated and help us offer future training to other members of the community. Full Name /. Are you requesting a training or will you be attending a training? Q Requesting 0 Will be Attending Please type your contact information. https: //unthsc.yul l Anal trics.com/Q/EditSecti on/RI ocks/Ajax/GetSurveyPrintPreview?ContextSurveylD=SV_eyzNvGRPIK2AjKC&ContextLibrarylD=UR_cApF9V ... 1/5 3/27/24, 4:25 PM Qualtrics Survey Software What is the name of your organization? l What dates would you be interested in receiving Narcan Training? l What is the name of the event or the location where you are receiving this training? Date of the training 7 What is your zipcode? https://unthsc.yul 1 .qualtrics.com/Q/FditSection/Blocks/Ajax/GetSurveyPrintPreview?ContextSurveyID=SV_eyzNvGRPIK2AjKC&ContextLibrarylD=UR_cApF9V ... 2/5 3/27/24, 4:25 PM Qualtrics Survey Software Which of the following best represents you or your institution? Select all that apply ❑ Police Department ❑ Fire Department ❑ Emergency Services ❑ Elementary/ Middle/ High School ❑ Public or Private University ❑ Community Care Clinic ❑ Public Health ❑ Primary Care Practice ❑ Recovery/ Treatment Center Provider ❑ Counseling Service Provider ❑ Medication Assisted Treatment Center ❑ Hospital ❑ City/ County/ State Representative ❑ Social Services ❑ Family or Child Protective Services ❑ Community Outreach ❑ Other Are you receiving this training as part of an organization? Q Yes Q No What areas do you or your organization commonly serve? (Example: Hemphill https://unthsc.yul 1 .qualtrics.com/Q/FditSection/Blocks/Ajax/GetSurveyPrintPreview?ContextSurveyID=SV_eyzNvGRPIK2AjKC&ContextLibrarylD=UR_cApF9V ... 3/5 3/27/24, 4:25 PM Qualtrics Survey Software neighborhood, areas northeast of 1-30 and 1-35, Como neighborhood) Approximately how many people does you or your organization serve? To which of these groups might you be supplying Narcan to? Select all that apply. 0 0 0 Youth/ Young adults Elderly Rural/ Remote People in Substance Use Treatment Programs Pregnant/ Postpartum Native American/ Tribal Criminal justice -involved LGBTQIA Veterans Low-income Other l https://unthsc.yul 1 .qualtrics.com/Q/FditSection/Blocks/Ajax/GetSurveyPrintPreview?ContextSurveyID=SV_eyzNvGRPIK2AjKC&ContextLibrarylD=UR_cApF9V ... 4/5 3/27/24.4:25 PM Qualtrics Survey Software How did you hear about this event? ❑ Friend/Family ❑ SaferCare Texas YouTube Training Video ❑ Website ❑ Newsletter ❑ Social media ❑ Workplace ❑ Community Organization ❑ Colleague/ Professional Network ❑ Other Is there another event/ organization or group of people you believe we should provide this training for? If so, please include that person or group's contact information below. /. Powered by Qualtrics https: //unthsc.yul l Anal trics.com/Q/EditSecti on/RI ocks/Ajax/GetSurveyPrintPreview?ContextSurveylD=SV_eyzNvGRPIK2AjKC&ContextLibrarylD=UR_cApF9V ... 5/5 Narcan Training Post Survey Start of Block: Default Question Block Q25 Study: UNT Health Science Center Opioid Abatement Program Community Training Thank you for participating in our training session. Your completion of this post -training survey will help us evaluate our training program! Q5 Which of these below are NOT true about opioids in the United States. Opioid prescriptions are increasing (1) © The majority of drug overdose deaths involve an opioid (2) © Heroin is the cause of most opioid related deaths (3) © Synthetic opioid deaths began to increase in 2013 (4) Q6 is a synthetic opioid, approved for treating severe pain. It is prescribed in the form of patches placed on the skin, pills or lozenges. Naloxone (1) Narcan (2) Heroin (3) Fentanyl (4) Page 1 of 6 Q7 Which of these is a sign of opioid overdose? Small constricted pinpoint pupils (1) Hyperactivity (2) Racing heart rate (3) Darkened, red or hot skin (4) Q8 Narcan, a nasal spray that can be used for an opioid overdose is known as: Naloxone (1) Heroin (2) Hydrocodone (3) Fentanyl (4) Q9 When administering Narcan, which of the choices below is NOT advised? Call 911 (1) Tilt head and lift chin (2) Test the plunger by depressing it before putting it in the nose (3) Insert fully into one nostril (4) Page 2 of 6 Q10 Which of these is the recovery position? D Seated upright in a chair (1) O On their left side with hand under head (2) O On their back with hands on chest (3) O On their stomach with their head placed sideways (4) Q11 You should call 911 if you administer Narcan. O True (1) O False (2) Q12 Expired Narcan should be: O Flushed down the toilet (1) O Placed in a water bottle and put in the trash (2) O Given to a drug -take back location or disposed of using FDA guidelines (3) O Donated to Goodwill (4) Page 3 of 6 Q27 I am confident that I can successfully administer Narcan Very true (1) © Somewhat true (2) Q Neither true or false (3) Q Somewhat false (4) O Very false (5) Q28 I am confident I can safely dispose of unused medicine. Very true (1) Somewhat true (2) Neither true or false (3) Somewhat false (4) Very false (5) Page 4of6 Q31 What is your level of satisfaction with this training? D Extremely dissatisfied (1) O Moderately dissatisfied (2) O Slightly dissatisfied (3) O Neither satisfied nor dissatisfied (4) © Slightly satisfied (5) © Moderately satisfied (6) Extremely satisfied (7) Q26 To assess the usefulness of this training, we ask participants to complete this survey before and after the training. Although we do not collect any identifying information during this surveys, we would like to be able to match your pre and post responses for review. Therefore, the question below is for matching purposes only. Write the first letter of your LAST name. For example, if your last name is Smart, put an "S" in this box. (1) Write the number corresponding to your birth month. For example, if you were born in October, write "10" in this box. (2) Write the last two digits of your birth year. For example, if you were born in 1979, write "79" in this box. (3) Q29 What are your suggestions to improve this training? Page 5 of 6 Q30 Is there an organization you believe we should offer this training to? If so, please identify them below: Name of the organization (1) Name of a contact person if available (2) End of Block: Default Question Block Page 6 of 6 EXHIBIT E List of Opioid Remediation Uses Schedule A Core Strategies States and Qualifying Block Grantees shall choose from among the abatement strategies listed in Schedule B. However, priority shall be given to the following core abatement strategies ("Core Strategies").14 A. NALOXONE OR OTHER FDA -APPROVED DRUG TO REVERSE OPIOID OVERDOSES 1. Expand training for first responders, schools, community support groups and families; and 2. Increase distribution to individuals who are uninsured or whose insurance does not cover the needed service. B. MEDICATION -ASSISTED TREATMENT ("MAT") DISTRIBUTION AND OTHER OPIOID-RELATED TREATMENT 1. Increase distribution of MAT to individuals who are uninsured or whose insurance does not cover the needed service; 2. Provide education to school -based and youth -focused programs that discourage or prevent misuse; 3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, and other first responders; and 4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services. 14 As used in this Schedule A, words like "expand," "fund," "provide" or the like shall not indicate a preference for new or existing programs. E-1 C. PREGNANT & POSTPARTUM WOMEN 1. Expand Screening, Brief Intervention, and Referral to Treatment ("SBIRT") services to non -Medicaid eligible or uninsured pregnant women; 2. Expand comprehensive evidence -based treatment and recovery services, including MAT, for women with co- occurring Opioid Use Disorder ("OUD") and other Substance Use Disorder ("SUD")/Mental Health disorders for uninsured individuals for up to 12 months postpartum; and 3. Provide comprehensive wrap -around services to individuals with OUD, including housing, transportation, job placement/training, and childcare. D. EXPANDING TREATMENT FOR NEONATAL ABSTINENCE SYNDROME ("NAS") 1. Expand comprehensive evidence -based and recovery support for NAS babies; 2. Expand services for better continuum of care with infant - need dyad; and 3. Expand long-term treatment and services for medical monitoring of NAS babies and their families. E. EXPANSION OF WARM HAND-OFF PROGRAMS AND RECOVERY SERVICES 1. Expand services such as navigators and on -call teams to begin MAT in hospital emergency departments; 2. Expand warm hand-off services to transition to recovery services; 3. Broaden scope of recovery services to include co-occurring SUD or mental health conditions; 4. Provide comprehensive wrap -around services to individuals in recovery, including housing, transportation, job placement/training, and childcare; and 5. Hire additional social workers or other behavioral health workers to facilitate expansions above. F. TREATMENT FOR INCARCERATED POPULATION 1. Provide evidence -based treatment and recovery support, including MAT for persons with OUD and co-occurring SUD/MH disorders within and transitioning out of the criminal justice system; and 2. Increase funding for jails to provide treatment to inmates with OUD. G. PREVENTION PROGRAMS 1. Funding for media campaigns to prevent opioid use (similar to the FDA's "Real Cost" campaign to prevent youth from misusing tobacco); 2. Funding for evidence -based prevention programs in schools; 3. Funding for medical provider education and outreach regarding best prescribing practices for opioids consistent with the 2016 CDC guidelines, including providers at hospitals (academic detailing); 4. Funding for community drug disposal programs; and 5. Funding and training for first responders to participate in pre -arrest diversion programs, post -overdose response teams, or similar strategies that connect at -risk individuals to behavioral health services and supports. H. EXPANDING SYRINGE SERVICE PROGRAMS 1. Provide comprehensive syringe services programs with more wrap -around services, including linkage to OUD treatment, access to sterile syringes and linkage to care and treatment of infectious diseases. I. EVIDENCE -BASED DATA COLLECTION AND RESEARCH ANALYZING THE EFFECTIVENESS OF THE ABATEMENT STRATEGIES WITHIN THE STATE Schedule B Approved Uses Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use Disorder or Mental Health (SUD/MH) conditions through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, the following: PART ONE: TREATMENT A. TREAT OPIOID USE DISORDER (OUD) Support treatment of Opioid Use Disorder ("OUD") and any co-occurring Substance Use Disorder or Mental Health ("SUD/MH") conditions through evidence -based or evidence - informed programs or strategies that may include, but are not limited to, those that:15 1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, including all forms of Medication -Assisted Treatment ("MAP') approved by the U.S. Food and Drug Administration. 2. Support and reimburse evidence -based services that adhere to the American Society of Addiction Medicine ("ASAM") continuum of care for OUD and any co- occurring SUD/MH conditions. 3. Expand telehealth to increase access to treatment for OUD and any co-occurring SUD/MH conditions, including MAT, as well as counseling, psychiatric support, and other treatment and recovery support services. 4. Improve oversight of Opioid Treatment Programs ("OTPs") to assure evidence - based or evidence -informed practices such as adequate methadone dosing and low threshold approaches to treatment. 5. Support mobile intervention, treatment, and recovery services, offered by qualified professionals and service providers, such as peer recovery coaches, for persons with OUD and any co-occurring SUD/MH conditions and for persons who have experienced an opioid overdose. 6. Provide treatment of trauma for individuals with OUD (e.g., violence, sexual assault, human trafficking, or adverse childhood experiences) and family members (e.g., surviving family members after an overdose or overdose fatality), and training of health care personnel to identify and address such trauma. 7. Support evidence -based withdrawal management services for people with OUD and any co-occurring mental health conditions. 15 As used in this Schedule B, words like "expand," "fund," "provide" or the like shall not indicate a preference for new or existing programs. E-4 8. Provide training on MAT for health care providers, first responders, students, or other supporting professionals, such as peer recovery coaches or recovery outreach specialists, including telementoring to assist community -based providers in rural or underserved areas. 9. Support workforce development for addiction professionals who work with persons with OUD and any co-occurring SUD/MH conditions. 10. Offer fellowships for addiction medicine specialists for direct patient care, instructors, and clinical research for treatments. 11. Offer scholarships and supports for behavioral health practitioners or workers involved in addressing OUD and any co-occurring SUD/MH or mental health conditions, including, but not limited to, training, scholarships, fellowships, loan repayment programs, or other incentives for providers to work in rural or underserved areas. 12. Provide funding and training for clinicians to obtain a waiver under the federal Drug Addiction Treatment Act of 2000 ("DATA 2000") to prescribe MAT for OUD, and provide technical assistance and professional support to clinicians who have obtained a DATA 2000 waiver. 13. Disseminate of web -based training curricula, such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service—Opioids web -based training curriculum and motivational interviewing. 14. Develop and disseminate new curricula, such as the American Academy of Addiction Psychiatry's Provider Clinical Support Service for Medication — Assisted Treatment. B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY Support people in recovery from OUD and any co-occurring SUD/MH conditions through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, the programs or strategies that: 1. Provide comprehensive wrap -around services to individuals with OUD and any co-occurring SUD/MH conditions, including housing, transportation, education, job placement, job training, or childcare. 2. Provide the full continuum of care of treatment and recovery services for OUD and any co-occurring SUD/MH conditions, including supportive housing, peer support services and counseling, community navigators, case management, and connections to community -based services. 3. Provide counseling, peer -support, recovery case management and residential treatment with access to medications for those who need it to persons with OUD and any co-occurring SUD/MH conditions. E-5 4. Provide access to housing for people with OUD and any co-occurring SUD/MH conditions, including supportive housing, recovery housing, housing assistance programs, training for housing providers, or recovery housing programs that allow or integrate FDA -approved mediation with other support services. 5. Provide community support services, including social and legal services, to assist in deinstitutionalizing persons with OUD and any co-occurring SUD/MH conditions. 6. Support or expand peer -recovery centers, which may include support groups, social events, computer access, or other services for persons with OUD and any co-occurring SUD/MH conditions. 7. Provide or support transportation to treatment or recovery programs or services for persons with OUD and any co-occurring SUD/MH conditions. 8. Provide employment training or educational services for persons in treatment for or recovery from OUD and any co-occurring SUD/MH conditions. 9. Identify successful recovery programs such as physician, pilot, and college recovery programs, and provide support and technical assistance to increase the number and capacity of high -quality programs to help those in recovery. 10. Engage non -profits, faith -based communities, and community coalitions to support people in treatment and recovery and to support family members in their efforts to support the person with OUD in the family. 11. Provide training and development of procedures for government staff to appropriately interact and provide social and other services to individuals with or in recovery from OUD, including reducing stigma. 12. Support stigma reduction efforts regarding treatment and support for persons with OUD, including reducing the stigma on effective treatment. 13. Create or support culturally appropriate services and programs for persons with OUD and any co-occurring SUD/MH conditions, including new Americans. 14. Create and/or support recovery high schools. 15. Hire or train behavioral health workers to provide or expand any of the services or supports listed above. C. CONNECT PEOPLE WHO NEED HELP TO THE HELP THEY NEED (CONNECTIONS TO CARE) Provide connections to care for people who have —or are at risk of developing—OUD and any co-occurring SUD/MH conditions through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, those that: E-6 1. Ensure that health care providers are screening for OUD and other risk factors and know how to appropriately counsel and treat (or refer if necessary) a patient for OUD treatment. 2. Fund SBIRT programs to reduce the transition from use to disorders, including SBIRT services to pregnant women who are uninsured or not eligible for Medicaid. 3. Provide training and long-term implementation of SBIRT in key systems (health, schools, colleges, criminal justice, and probation), with a focus on youth and young adults when transition from misuse to opioid disorder is common. 4. Purchase automated versions of SBIRT and support ongoing costs of the technology. 5. Expand services such as navigators and on -call teams to begin MAT in hospital emergency departments. 6. Provide training for emergency room personnel treating opioid overdose patients on post -discharge planning, including community referrals for MAT, recovery case management or support services. 7. Support hospital programs that transition persons with OUD and any co-occurring SUD/MH conditions, or persons who have experienced an opioid overdose, into clinically appropriate follow-up care through a bridge clinic or similar approach. 8. Support crisis stabilization centers that serve as an alternative to hospital emergency departments for persons with OUD and any co-occurring SUD/MH conditions or persons that have experienced an opioid overdose. 9. Support the work of Emergency Medical Systems, including peer support specialists, to connect individuals to treatment or other appropriate services following an opioid overdose or other opioid-related adverse event. 10. Provide funding for peer support specialists or recovery coaches in emergency departments, detox facilities, recovery centers, recovery housing, or similar settings; offer services, supports, or connections to care to persons with OUD and any co-occurring SUD/MH conditions or to persons who have experienced an opioid overdose. 11. Expand warm hand-off services to transition to recovery services. 12. Create or support school -based contacts that parents can engage with to seek immediate treatment services for their child; and support prevention, intervention, treatment, and recovery programs focused on young people. 13. Develop and support best practices on addressing OUD in the workplace. E-7 14. Support assistance programs for health care providers with OUD. 15. Engage non -profits and the faith community as a system to support outreach for treatment. 16. Support centralized call centers that provide information and connections to appropriate services and supports for persons with OUD and any co-occurring SUD/MH conditions. D. ADDRESS THE NEEDS OF CRIMINAL JUSTICE -INVOLVED PERSONS Address the needs of persons with OUD and any co-occurring SUD/MH conditions who are involved in, are at risk of becoming involved in, or are transitioning out of the criminal justice system through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, those that: 1. Support pre -arrest or pre -arraignment diversion and deflection strategies for persons with OUD and any co-occurring SUD/MH conditions, including established strategies such as: 1. Self -referral strategies such as the Angel Programs or the Police Assisted Addiction Recovery Initiative ("PAARI"); 2. Active outreach strategies such as the Drug Abuse Response Team ("DART') model; 3. "Naloxone Plus" strategies, which work to ensure that individuals who have received naloxone to reverse the effects of an overdose are then linked to treatment programs or other appropriate services; 4. Officer prevention strategies, such as the Law Enforcement Assisted Diversion ("LEAD") model; 5. Officer intervention strategies such as the Leon County, Florida Adult Civil Citation Network or the Chicago Westside Narcotics Diversion to Treatment Initiative; or 6. Co -responder and/or alternative responder models to address OUD-related 911 calls with greater SUD expertise. 2. Support pre-trial services that connect individuals with OUD and any co- occurring SUD/MH conditions to evidence -informed treatment, including MAT, and related services. 3. Support treatment and recovery courts that provide evidence -based options for persons with OUD and any co-occurring SUD/MH conditions. E-8 4. Provide evidence -informed treatment, including MAT, recovery support, harm reduction, or other appropriate services to individuals with OUD and any co- occurring SUD/MH conditions who are incarcerated in jail or prison. 5. Provide evidence -informed treatment, including MAT, recovery support, harm reduction, or other appropriate services to individuals with OUD and any co- occurring SUD/MH conditions who are leaving jail or prison or have recently left jail or prison, are on probation or parole, are under community corrections supervision, or are in re-entry programs or facilities. 6. Support critical time interventions ("CTI"), particularly for individuals living with dual -diagnosis OUD/serious mental illness, and services for individuals who face immediate risks and service needs and risks upon release from correctional settings. 7. Provide training on best practices for addressing the needs of criminal justice - involved persons with OUD and any co-occurring SUD/MH conditions to law enforcement, correctional, or judicial personnel or to providers of treatment, recovery, harm reduction, case management, or other services offered in connection with any of the strategies described in this section. E. ADDRESS THE NEEDS OF PREGNANT OR PARENTING WOMEN AND THEIR FAMILIES, INCLUDING BABIES WITH NEONATAL ABSTINENCE SYNDROME Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH conditions, and the needs of their families, including babies with neonatal abstinence syndrome ("NAS"), through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, those that: 1. Support evidence -based or evidence -informed treatment, including MAT, recovery services and supports, and prevention services for pregnant women —or women who could become pregnant —who have OUD and any co-occurring SUD/MH conditions, and other measures to educate and provide support to families affected by Neonatal Abstinence Syndrome. 2. Expand comprehensive evidence -based treatment and recovery services, including MAT, for uninsured women with OUD and any co-occurring SUD/MH conditions for up to 12 months postpartum. 3. Provide training for obstetricians or other healthcare personnel who work with pregnant women and their families regarding treatment of OUD and any co- occurring SUD/MH conditions. 4. Expand comprehensive evidence -based treatment and recovery support for NAS babies; expand services for better continuum of care with infant -need dyad; and expand long-term treatment and services for medical monitoring of NAS babies and their families. E-9 5. Provide training to health care providers who work with pregnant or parenting women on best practices for compliance with federal requirements that children born with NAS get referred to appropriate services and receive a plan of safe care. 6. Provide child and family supports for parenting women with OUD and any co- occurring SUD/MH conditions. 7. Provide enhanced family support and child care services for parents with OUD and any co-occurring SUD/MH conditions. 8. Provide enhanced support for children and family members suffering trauma as a result of addiction in the family; and offer trauma -informed behavioral health treatment for adverse childhood events. 9. Offer home -based wrap -around services to persons with OUD and any co- occurring SUD/MH conditions, including, but not limited to, parent skills training. 10. Provide support for Children's Services —Fund additional positions and services, including supportive housing and other residential services, relating to children being removed from the home and/or placed in foster care due to custodial opioid use. PART TWO: PREVENTION F. PREVENT OVER -PRESCRIBING AND ENSURE APPROPRIATE PRESCRIBING AND DISPENSING OF OPIOIDS Support efforts to prevent over -prescribing and ensure appropriate prescribing and dispensing of opioids through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, the following: 1. Funding medical provider education and outreach regarding best prescribing practices for opioids consistent with the Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease Control and Prevention, including providers at hospitals (academic detailing). 2. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and tapering patients off opioids. 3. Continuing Medical Education (CME) on appropriate prescribing of opioids. 4. Providing Support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi -modal, evidence -informed treatment of pain. 5. Supporting enhancements or improvements to Prescription Drug Monitoring Programs ("PDMPs"), including, but not limited to, improvements that: E-10 1. Increase the number of prescribers using PDMPs; 2. Improve point -of -care decision -making by increasing the quantity, quality, or format of data available to prescribers using PDMPs, by improving the interface that prescribers use to access PDMP data, or both; or 3. Enable states to use PDMP data in support of surveillance or intervention strategies, including MAT referrals and follow-up for individuals identified within PDMP data as likely to experience OUD in a manner that complies with all relevant privacy and security laws and rules. 6. Ensuring PDMPs incorporate available overdose/naloxone deployment data, including the United States Department of Transportation's Emergency Medical Technician overdose database in a manner that complies with all relevant privacy and security laws and rules. 7. Increasing electronic prescribing to prevent diversion or forgery. 8. Educating dispensers on appropriate opioid dispensing. G. PREVENT MISUSE OF OPIOIDS Support efforts to discourage or prevent misuse of opioids through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, the following: 1. Funding media campaigns to prevent opioid misuse. 2. Corrective advertising or affirmative public education campaigns based on evidence. 3. Public education relating to drug disposal. 4. Drug take -back disposal or destruction programs. 5. Funding community anti -drug coalitions that engage in drug prevention efforts. 6. Supporting community coalitions in implementing evidence -informed prevention, such as reduced social access and physical access, stigma reduction —including staffing, educational campaigns, support for people in treatment or recovery, or training of coalitions in evidence -informed implementation, including the Strategic Prevention Framework developed by the U.S. Substance Abuse and Mental Health Services Administration ("SAMHSA"). 7. Engaging non -profits and faith -based communities as systems to support prevention. E-11 8. Funding evidence -based prevention programs in schools or evidence -informed school and community education programs and campaigns for students, families, school employees, school athletic programs, parent -teacher and student associations, and others. 9. School -based or youth -focused programs or strategies that have demonstrated effectiveness in preventing drug misuse and seem likely to be effective in preventing the uptake and use of opioids. 10. Create or support community -based education or intervention services for families, youth, and adolescents at risk for OUD and any co-occurring SUD/MH conditions. 11. Support evidence -informed programs or curricula to address mental health needs of young people who may be at risk of misusing opioids or other drugs, including emotional modulation and resilience skills. 12. Support greater access to mental health services and supports for young people, including services and supports provided by school nurses, behavioral health workers or other school staff, to address mental health needs in young people that (when not properly addressed) increase the risk of opioid or another drug misuse. H. PREVENT OVERDOSE DEATHS AND OTHER HARMS (HARM REDUCTION) Support efforts to prevent or reduce overdose deaths or other opioid-related harms through evidence -based or evidence -informed programs or strategies that may include, but are not limited to, the following: 1. Increased availability and distribution of naloxone and other drugs that treat overdoses for first responders, overdose patients, individuals with OUD and their friends and family members, schools, community navigators and outreach workers, persons being released from jail or prison, or other members of the general public. 2. Public health entities providing free naloxone to anyone in the community. 3. Training and education regarding naloxone and other drugs that treat overdoses for first responders, overdose patients, patients taking opioids, families, schools, community support groups, and other members of the general public. 4. Enabling school nurses and other school staff to respond to opioid overdoses, and provide them with naloxone, training, and support. 5. Expanding, improving, or developing data tracking software and applications for overdoses/naloxone revivals. 6. Public education relating to emergency responses to overdoses. E- 12 7. Public education relating to immunity and Good Samaritan laws. 8. Educating first responders regarding the existence and operation of immunity and Good Samaritan laws. 9. Syringe service programs and other evidence -informed programs to reduce harms associated with intravenous drug use, including supplies, staffing, space, peer support services, referrals to treatment, fentanyl checking, connections to care, and the full range of harm reduction and treatment services provided by these programs. 10. Expanding access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting from intravenous opioid use. 11. Supporting mobile units that offer or provide referrals to harm reduction services, treatment, recovery supports, health care, or other appropriate services to persons that use opioids or persons with OUD and any co-occurring SUD/MH conditions. 12. Providing training in harm reduction strategies to health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with OUD and any co- occurring SUD/MH conditions. 13. Supporting screening for fentanyl in routine clinical toxicology testing. PART THREE: OTHER STRATEGIES I. FIRST RESPONDERS In addition to items in section C, D and H relating to first responders, support the following: 1. Education of law enforcement or other first responders regarding appropriate practices and precautions when dealing with fentanyl or other drugs. 2. Provision of wellness and support services for first responders and others who experience secondary trauma associated with opioid-related emergency events. J. LEADERSHIP, PLANNING AND COORDINATION Support efforts to provide leadership, planning, coordination, facilitations, training and technical assistance to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, the following: 1. Statewide, regional, local or community regional planning to identify root causes of addiction and overdose, goals for reducing harms related to the opioid epidemic, and areas and populations with the greatest needs for treatment E-13 intervention services, and to support training and technical assistance and other strategies to abate the opioid epidemic described in this opioid abatement strategy list. 2. A dashboard to (a) share reports, recommendations, or plans to spend opioid settlement funds; (b) to show how opioid settlement funds have been spent; (c) to report program or strategy outcomes; or (d) to track, share or visualize key opioid- or health -related indicators and supports as identified through collaborative statewide, regional, local or community processes. 3. Invest in infrastructure or staffing at government or not -for -profit agencies to support collaborative, cross -system coordination with the purpose of preventing overprescribing, opioid misuse, or opioid overdoses, treating those with OUD and any co-occurring SUD/MH conditions, supporting them in treatment or recovery, connecting them to care, or implementing other strategies to abate the opioid epidemic described in this opioid abatement strategy list. 4. Provide resources to staff government oversight and management of opioid abatement programs. K. TRAINING In addition to the training referred to throughout this document, support training to abate the opioid epidemic through activities, programs, or strategies that may include, but are not limited to, those that: 1. Provide funding for staff training or networking programs and services to improve the capability of government, community, and not -for -profit entities to abate the opioid crisis. 2. Support infrastructure and staffing for collaborative cross -system coordination to prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- occurring SUD/MH conditions, or implement other strategies to abate the opioid epidemic described in this opioid abatement strategy list (e.g., health care, primary care, pharmacies, PDMPs, etc.). L. RESEARCH Support opioid abatement research that may include, but is not limited to, the following: 1. Monitoring, surveillance, data collection and evaluation of programs and strategies described in this opioid abatement strategy list. 2. Research non-opioid treatment of chronic pain. 3. Research on improved service delivery for modalities such as SBIRT that demonstrate promising but mixed results in populations vulnerable to opioid use disorders. E-14 4. Research on novel harm reduction and prevention efforts such as the provision of fentanyl test strips. 5. Research on innovative supply-side enforcement efforts such as improved detection of mail -based delivery of synthetic opioids. 6. Expanded research on swift/certain/fair models to reduce and deter opioid misuse within criminal justice populations that build upon promising approaches used to address other substances (e.g., Hawaii HOPE and Dakota 24/7). 7. Epidemiological surveillance of OUD-related behaviors in critical populations, including individuals entering the criminal justice system, including, but not limited to approaches modeled on the Arrestee Drug Abuse Monitoring ("ADAM") system. 8. Qualitative and quantitative research regarding public health risks and harm reduction opportunities within illicit drug markets, including surveys of market participants who sell or distribute illicit opioids. 9. Geospatial analysis of access barriers to MAT and their association with treatment engagement and treatment outcomes. 2025 Documentation Standards for IOU Contract Expenses oc s damrW w Budget Line Items m be c m Notes/Other 0.aetoa, 000tatf.o 2a`waw da` Employee Salaries and Benefits - City will only reimburse a percentage of any employee's salary and benefits who work directly with the IOU -funded Program. Percentages will be cost allocated and determined prior to the execution of the IOU Contract. Agencies requesting the reimbursement of 100% of any Agency employee will require prior City approval. Agencies must show calculation on how the IOU portion of employee salaries and benefits were calculated consistently with the IOU Contract. Salaries X x" If an employee works on both an IOU eligible and non -IOU eligible program(s), the City will only reimburse for a reasonable portion of the employee's salary. Prior to the execution of the IOU Contract, the Agency will provide the City with a written statement on how each employee's time will be allocated. If an employee works 100% of their time directly with the IOU Program, then 100% of the employee's salary may be eligible for reimbursement. Agency must submit a written statement that 100% of the employee's time is spent working directly with the IOU Program. Statements must be signed by a person authorized to sign on behalf of the Agency and will be submitted with the March invoice. Reimbursement requests must include General ledger and payroll reports that reflect the amount paid to the employee for work on the IOU Program. Bi-Annual Effort Reports must be submiited as they are certified, and must reflect the percent of effort worked by the employee(s) working directly on the IOU Program. For employees who are paid with multiple funding sources, Effort of Certification must reflect all funding sources. If seperate Effort of Certification are kept for each funding source, all such Effort of Certification must be submitted to City, Effort of Certification must be signed by Principal Investigator (PI). Agency must show a calculation and documentation of how the employee's salary was calculated and invoiced to City. In the event that bi-annual effort reports reflect overpayment by the City, an amount equal to the overpayment will, at the option of the City, be deducted from the next invoice or returned to the City. *If employees are paid by direct deposit rather than check, then the agency must submit both the direct deposit payment company's report (such as an ADT report) and a bank statement or check showing payment to the direct deposit company. FICA/Medicare X X X If the City pays gross salary, this is already included. Invoice and proof of payment are only required with the first reimbursement request and at any time there are changes to amounts, enrollments, disenrollments, etc. Employee Insurance x x x Unemployment Insurance x x x Retirement x x x Materials, Equipment, Goods and Supplies - City will only reimburse for the cost allocated percent or amount spent in support of the IOU -funded Program. Agencies requesting reimbursement for these items will require prior City approval. Agencies must show calculation on how the IOU portion of these expenses were calculated consistently with the IOU Contract. Naloxone Kits X X Small Deterra Drug Pouches X X Harm Reduction Kits X X Overdose Prevention Kits X X Medication - Assisted Treatment X X Response Vehicle X X Proof Effetive on March 1, 2024 Payments or Expenses must be documented in the following manner: A) Image of the check AND bank statement showing the check cleared the bank; OR, B) Image of the cancelled check (ex. At end of bank statement); OR, C) Payroll Check Stub, "Advice", or Statement AND Bank Statement indicating payroll; OR, D) For wire or e-transfers: Reciept or statement from payee/vendor OR bank statement, OR E) Invoice and Proof of payment. IOU Contract Exhibit "F" -- STANDARDS FOR COMPLETE DOCUMENTATION IOU Contract Exhibit "F" -- STANDARDS FOR COMPLETE DOCUMENTATION M&C Review Page 1 of 4 CITY COUNCIL AGENDA Create New From This M&C DATE: 6/24/2025 REFERENCE M&C 25- LOG NAME: NO.: 0586 Official site of the City of Fort Worth, Texas FORT TH 19INTERVENTIONS OF OPIOID USE FUNDING ALLOCATIONS 2025 CODE: G TYPE: NON- PUBLIC NO CONSENT HEARING: SUBJECT: (ALL) Authorize Execution of a Contract with the University of North Texas Health Science Center at Fort Worth Health Systems in an Amount Up to $227,156.00 for the Purpose of Mitigating Harms Caused by Opioid Distribution and Use and Adopt Appropriation Ordinance Increasing Estimated Receipts and Appropriations in the Grants Operating Other Fund by $761,379.85 for Allowable Expenses Related to Core Strategies and Broader Approved Uses as Provided by the Texas Opioid Abatement Fund Council for the TX Opioid Abatement Fund Project RECOMMENDATION: It is recommended that the City Council: 1. Authorize the City Manager or his designee to execute a contract for a one-year term with the University of North Texas Health Science Center at Fort Worth Health Systems in an amount up to $227,156.00; 2. Authorize the City Manager or his designee to extend the contract for up to one year if the agency requests an extension and such extension is necessary for completion of the program, or to amend the contract if necessary to achieve program goals provided any amendment is within the scope of the program and in compliance with City policies and all applicable laws and regulations governing the use of these funds; and 3. Adopt the attached appropriation ordinance increasing estimated receipts and appropriations in the Grants Operating Other Fund in the amount of $761,379.85 for allowable expenses related to core strategies and broader approved uses as provided by the Texas Opioid Abatement Fund Council for the Texas Opioid Abatement Fund project (City Project No. 104782). DISCUSSION: Through the adoption of Resolution 5499-11-2021, adopted November 9, 2021, City Council joined the opioid settlement negotiated by the Texas Attorney General, affirmed its support for the adoption and approval of the Texas Opioid Abatement Fund Council and Settlement Allocation Term Sheet (Term Sheet) in its entirety, and found that there is a substantial need for repayment of opioid- related expenditures and payment to abate opioid-related harms in and about Fort Worth. On March 1, 2023, the City received the first settlement payment from the Opioid Abatement Fund Council in the amount of $665,760.73 and approved use of the funds with Mayor & Council Communication (M&C) 23-0255 on April 11, 2023. The Neighborhood Services Department (NSD) was designated as the lead department to oversee allocation and use of these funds. The first round of Opioid Abatement Funds were awarded to the University of North Texas Health Science Center at Fort Worth Health Systems (HSC) and My Health My Resources of Tarrant County (MHMR) through a competitive Request for Proposals (RFP) process, and to the Fort Worth Fire Department (FWFD) through a Memorandum of Understanding (MOU). These one-year awards were approved through M&C 23-1051. On April 16, 2024, the City received its second settlement payment from the Opioid Abatement Fund Council in the amount of $129,518.88. On April 10, 2025, the City received its third settlement http://apps.cfwnet.org/council_packet/mc review.asp?M=33447&councildate=6/24/2025 9/3/2025 M&C Review Page 2 of 4 payment from the Opioid Abatement Fund Council in the amount of $631,860.97. The second and third settlement payments totaling $761,379.85 need to be appropriated to increase the receipts and appropriations in the Grants Operating Other Fund for the purpose of allowable expenses related to core strategies and broader approved uses as provided by the Texas Opioid Abatement Fund Council for the Texas Opioid Abatement Fund project (City Project No. 104782). In addition, in January 2025, NSD and FWFD staff mutually agreed to amend their MOU and reduce the allocation to FWFD from $157,500.00 to $59,640.48 due to external factors that affected the pace of fund expenditure. This brought the balance remaining from the first settlement to $97,859.52. The total amount of available funds from the Texas Opioid Abatement Fund Council is $859,239.37. This figure represents the total of the remaining unallocated balance of the first settlement, the second settlement, and the third settlement. Settlement Received Funds Received Funds Expended Funds Remaining #1-March 1, 2023 $665,760.73 $567,901.21 $97,859.52 #2- April 16, 2024 $129,518.88 $0.00 $129,518.88 #3-April 10, 2025 $631,860.97 $0.00 $631,860.97 Total: $1,427,140.58 $567,901.21 $859,239.37 A Request for Proposals (RFP) from nonprofit and social service agencies and City departments offering similar direct social services to respond for the intervention, prevention, and treatment of opioid use disorder (OUD) and any co-occurring Substance Use Disorder or Mental Health (SUD/MH) conditions through evidence -based or evidence -informed programs or activities was published on March 10, 2025. To notify potential applicant staff provided the information to the public via emails sent to community partners on March 3, 2025, an information session held in person at the Mental Health Connections Meeting on March 3, 2025, a virtual information session held on March 18, 2025, and through a Public Notice that was published on the City of Fort Worth's Neighborhood Services Department website from March 3, 2025 through March 31, 2025. This program is named Interventions Of Opioid Use (IOU). All proposals were received by March 31, 2025. Staff reviewed one (1) proposal and developed recommendations for allocation of funding based on the capacity of applicant organization and the amount of funds they requested. Eligible activities under this RFP included but were not limited to: • Intervention • Prevention • Treatment • Anything listed as eligible in Exhibit E-List of Opioid Remediation Uses (attached) FUNDING RECOMMENDATIONS Neighborhood Services Department staff recommends that funding consisting of the combined unallocated balance from the first settlement and the full balance from the second settlement —totaling $227,156.00— be allocated as shown in the below table and contracts be executed with the organization listed. The third settlement will be distributed through a RFP which will be released at a later date. AGENCY NAME PROGRAM NAME PROGRAM DESCRIPTION REQUESTED FUNDING AMOUNT RECOMMENDED FUNDING AMOUNT UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE SaferCare Texas Community -based intervention operating as the SaferCare Texas program with clinical $227,156.00 $227,156.00 http://apps.cfwnet.org/council_packet/mc review.asp?ID=33447&councildate=6/24/2025 9/3/2025 M&C Review Page 3 of 4 CENTER AT FORT WORTH HEALTH SYSTEMS executives comprised of nurses and nurse practitioners to distribute 250 naloxone kits and 500 drug disposal bags including 10 organizational readiness kits accompanied by educational training of trainers among Fort Worth based organizations and groups who primarily serve mothers and families and respond to this opportunity. This proposed program is an eligible activity for the use of the Texas Opioid batement Fund per the List of Opioid Remediation Uses attached. TOTAL $227.156.00 The Agreement with the University of North Texas Health Science Center at Fort Worth Health Systems will be for one year, beginning upon execution. The Agreement may be extended for up to one year if the agency requests an extension and such extension is necessary for completion of the program. This program is available in ALL COUNCIL DISTRICTS. FISCAL INFORMATION/CERTIFICATION: The Director of Finance certifies that funds are available in the current operating budget, as previously appropriated, in the Grants Operating Other Fund for the TX Opioid Abatement Fund project to support the approval of the above recommendations and execution of contract, and that upon adoption of the attached appropriation ordinance, funds will be available in the current operating budget, as appropriated, in the Grants Operating Other Fund for the TX Opioid Abatement Fund project. Prior to any expenditure being incurred, the Neighborhood Services Department has the responsibility to validate the availability of funds. TO Fund Department ID Account FROM Fund Department ID Account Project ID Project ID Program Program Activity Activity Budget Year Budget Year Reference # fChartfield 2) Amount Reference # (Chartfield 2) Amount http://apps.cfwnet.org/council_packet/mc review.asp?M=33447&councildate=6/24/2025 9/3/2025 M&C Review Page 4 of 4 Submitted for City Manager's Office by: Dana Burghdoff (8018) Originating Department Head: Kacey Bess (8187) Additional Information Contact: Kacey Bess (8187) ATTACHMENTS 19INTERVENTIONS OF OPIOID USE FUNDING ALLOCATIONS 2025 fund avail.docx (CFW Internal) 19INTERVENTIONS OF OPIOID USE FUNDING ALLOCATIONS 2025 fund avail.docx (CFW Internal) 456804 Wagner, T 1295 Form Signed.pdf (CFW Internal) FID Table - Opioid 104782 (1).xlsx (CFW Internal) LIST OF OPIOID REMEDIATION USES (002).PDF (Public) OPIOID ABATEMENT TERM SHEET.PDF (Public) ORD.APP 19INTERVENTIONS OF OPIOID USE FUNDING ALLOCATIONS 2025 21003 A025(r3).docx (Public) RESOLUTION 5499-11-2021. PDF (Public) http://apps.cfwnet.org/council_packet/mc review.asp?M=33447&councildate=6/24/2025 9/3/2025